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Abstract
Salmonella infection in poultry (Salmonella Pullorum, Salmonella Gallinarum and Salmonella arizonae)
has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of
Article 7 on disease proﬁle and impacts, Article 5 on the eligibility of Salmonella to be listed, Article 9
for the categorisation of Salmonella according to disease prevention and control rules as in Annex IV
and Article 8 on the list of animal species related to Salmonella. The assessment has been performed
following a methodology composed of information collection and compilation, expert judgement on
each criterion at individual and, if no consensus was reached before, also at collective level. The
output is composed of the categorical answer, and for the questions where no consensus was reached,
the different supporting views are reported. Details on the methodology used for this assessment are
explained in a separate opinion. According to the assessment performed, Salmonella can be
considered eligible to be listed for Union intervention as laid down in Article 5(3) of the AHL. The
disease would comply with the criteria as in Sections 4 and 5 of Annex IV of the AHL, for the
application of the disease prevention and control rules referred to in points (d) and (e) of Article 9(1).
The assessment here performed on compliance with the criteria as in Section 1 of Annex IV referred to
in point (a) of Article 9(1) is inconclusive. The main animal species to be listed for Salmonella
according to Article 8(3) criteria are all species of domestic poultry and wild species of mainly
Anseriformes and Galliformes, as indicated in the present opinion.
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
Keywords: Salmonella, S. Pullorum, Pullorum disease, S. Gallinarum, fowl typhoid, S. arizonae,
salmonellosis, Animal Health Law, listing, categorisation, impact
Requestor: European Commission
Question number: EFSA-Q-2016-00601
Correspondence: alpha@efsa.europa.eu
EFSA Journal 2017;15(8):4954www.efsa.europa.eu/efsajournal
Panel members: Dominique Bicout, Anette Bøtner, Andrew Butterworth, Paolo Calistri, Klaus Depner,
Sandra Edwards, Bruno Garin-Bastuji, Margaret Good, Christian Gortazar Schmidt, Virginie Michel,
Miguel Angel Miranda, Simon More, Søren Saxmose Nielsen, Mohan Raj, Liisa Sihvonen, Hans Spoolder,
Jan Arend Stegeman, Hans-Hermann Thulke, Antonio Velarde, Preben Willeberg and Christoph
Winckler.
Acknowledgements: The Panel wishes to thank Andy Wales and Rob Davies for the support
provided to this scientiﬁc output.
Suggested citation: EFSA AHAW Panel (EFSA Panel on Animal Health and Welfare), More S, Bøtner A,
Butterworth A, Calistri P, Depner K, Edwards S, Garin-Bastuji B, Good M, Gortazar Schmidt C, Michel V,
Miranda MA, Nielsen SS, Raj M, Sihvonen L, Spoolder H, Stegeman JA, Thulke H-H, Velarde A,
Willeberg P, Winckler C, Baldinelli F, Broglia A, Beltran-Beck B, Kohnle L and Bicout D, 2017. Scientiﬁc
Opinion on the assessment of listing and categorisation of animal diseases within the framework of the
Animal Health Law (Regulation (EU) No 2016/429): Salmonella infection in poultry with serotypes of
animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae). EFSA Journal 2017;15(8):4954,
50 pp. https://doi.org/10.2903/j.efsa.2017.4954
ISSN: 1831-4732
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
This is an open access article under the terms of the Creative Commons Attribution-NoDerivs License,
which permits use and distribution in any medium, provided the original work is properly cited and no
modiﬁcations or adaptations are made.
The EFSA Journal is a publication of the European Food
Safety Authority, an agency of the European Union.
AHL assessment on Salmonella infection in poultry (S. Pullorum, S. Gallinarum, S. arizonae)
www.efsa.europa.eu/efsajournal 2 EFSA Journal 2017;15(8):4954
Table of contents
Abstract................................................................................................................................................... 1
1. Introduction................................................................................................................................ 4
1.1. Background and Terms of Reference as provided by the requestor.................................................. 4
1.2. Interpretation of the Terms of Reference....................................................................................... 4
2. Data and methodologies .............................................................................................................. 4
3. Assessment................................................................................................................................. 4
3.1. Assessment according to Article 7 criteria...................................................................................... 4
3.1.1. Article 7(a) Disease Proﬁle ........................................................................................................... 4
3.1.1.1. Article 7(a)(i) Animal species concerned by the disease.................................................................. 4
3.1.1.2. Article 7(a)(ii) The morbidity and mortality rates of the disease in animal populations ...................... 7
3.1.1.3. Article 7(a)(iii) The zoonotic character of the disease ..................................................................... 9
3.1.1.4. Article 7(a)(iv) The resistance to treatments, including antimicrobial resistance................................ 9
3.1.1.5. Article 7(a)(v) The persistence of the disease in an animal population or the environment................ 9
3.1.1.6. Article 7(a)(vi) The routes and speed of transmission of the disease between animals,
and, when relevant, between animals and humans ........................................................................ 12
3.1.1.7. Article 7(a)(vii) The absence or presence and distribution of the disease in the Union,
where the disease is not present in the Union, the risk of its introduction into the Union .................. 14
3.1.1.8. Article 7(a)(viii) The existence of diagnostic and disease control tools ............................................. 16
3.1.2. Article 7(b) The impact of diseases ............................................................................................... 17
3.1.2.1. Article 7(b)(i) The impact of the disease on agricultural and aquaculture production and
other parts of the economy.......................................................................................................... 17
3.1.2.2. Article 7(b)(ii) The impact of the disease on human health............................................................. 18
3.1.2.3. Article 7(b)(iii) The impact of the disease on animal welfare ........................................................... 20
3.1.2.4. Article 7(b)(iv) The impact of the disease on biodiversity and the environment ................................ 21
3.1.3. Article 7(c) Its potential to generate a crisis situation and its potential use in bioterrorism ................ 21
3.1.4. Article 7(d) The feasibility, availability and effectiveness of the following disease prevention and
control measures......................................................................................................................... 22
3.1.4.1. Article 7(d)(i) Diagnostic tools and capacities................................................................................. 22
3.1.4.2. Article 7(d)(ii) Vaccination ............................................................................................................ 24
3.1.4.3. Article 7(d)(iii) Medical treatments ................................................................................................ 25
3.1.4.4. Article 7(d)(iv) Biosecurity measures ............................................................................................. 26
3.1.4.5. Article 7(d)(v) Restrictions on the movement of animals and products............................................. 27
3.1.4.6. Article 7(d)(vi) Killing of animals ................................................................................................... 28
3.1.4.7. Article 7(d)(vii) Disposal of carcasses and other relevant animal by-products ................................... 29
3.1.5. Article 7(e) The impact of disease prevention and control measures................................................ 30
3.1.5.1. Article 7(e)(i) The direct and indirect costs for the affected sectors and the economy as a whole...... 30
3.1.5.2. Article 7(e)(ii) The societal acceptance of disease prevention and control measures ......................... 32
3.1.5.3. Article 7(e)(iii) The welfare of affected subpopulations of kept and wild animals .............................. 32
3.1.5.4. Article 7(e)(iv) The environment and biodiversity ........................................................................... 33
3.2. Assessment according to Article 5 criteria...................................................................................... 33
3.2.1. Outcome of the assessment of Salmonella infection in poultry with serotypes of animal health relevance
(S. Pullorum, S. Gallinarum and S. arizonae) according to criteria of Article 5(3) of the AHL on its
eligibility to be listed..................................................................................................................... 34
3.3. Assessment according to Article 9 criteria...................................................................................... 34
3.3.1. Non-consensus questions............................................................................................................. 38
3.3.2. Outcome of the assessment of criteria in Annex IV for Salmonella infection in poultry with
serotypes of animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae) for the
purpose of categorisation as in Article 9 of the AHL ....................................................................... 40
3.4. Assessment of Article 8................................................................................................................ 43
4. Conclusions................................................................................................................................. 45
References............................................................................................................................................... 45
Abbreviations ........................................................................................................................................... 50
AHL assessment on Salmonella infection in poultry (S. Pullorum, S. Gallinarum, S. arizonae)
www.efsa.europa.eu/efsajournal 3 EFSA Journal 2017;15(8):4954
1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
The background and Terms of Reference (ToR) as provided by the European Commission for the
present document are reported in Section 1.2 of the scientiﬁc opinion on the ad hoc methodology
followed for the assessment of the disease to be listed and categorised according to the criteria of
Article 5, Annex IV according to Article 9, and 8 within the Animal Health Law (AHL) framework (EFSA
AHAW Panel, 2017).
1.2. Interpretation of the Terms of Reference
The interpretation of the ToR is as in Section 1.2 of the scientiﬁc opinion on the ad hoc methodology
followed for the assessment of the disease to be listed and categorised according to the criteria of Article
5, Annex IV according to Article 9, and 8 within the AHL framework (EFSA AHAW Panel, 2017).
The present document reports the results of assessment on Salmonella infection in poultry with
serotypes of animal health relevance (Salmonella Pullorum, Salmonella Gallinarum and Salmonella
arizonae) according to the criteria of the AHL articles as follows:
• Article 7: Salmonella proﬁle and impacts
• Article 5: eligibility of Salmonella to be listed
• Article 9: categorisation of Salmonella according to disease prevention and control rules as in
Annex IV
• Article 8: list of animal species related to Salmonella.
2. Data and methodologies
The methodology applied in this opinion is described in detail in a dedicated document about the
ad hoc method developed for assessing any animal disease for the listing and categorisation of
diseases within the AHL framework (EFSA AHAW Panel, 2017).
3. Assessment
3.1. Assessment according to Article 7 criteria
This section presents the assessment of Salmonella infection in poultry with serotypes of animal
health relevance (S. Pullorum, S. Gallinarum and S. arizonae) according to the Article 7 criteria of the
AHL and related parameters (see table 2 of the opinion on methodology (EFSA AHAW Panel, 2017)),
based on the information contained in the factsheet as drafted by the selected disease scientist (see
Section 2.1 of the scientiﬁc opinion on the ad hoc methodology) and amended by the AHAW Panel.
3.1.1. Article 7(a) Disease Proﬁle
It is important to note that only two serovars of Salmonella enterica subspecies arizonae are
considered to be of commercial signiﬁcance, and only in turkeys because of their ability to be
transmitted vertically from infected breeding ﬂocks. These closely related serovars are thought to have
been eradicated from all major turkey breeding nations, but their occurrence in low income countries
or wild turkey populations is uncertain.
3.1.1.1. Article 7(a)(i) Animal species concerned by the disease
Susceptible animal species
Parameter 1 – Naturally susceptible wildlife species (or family/orders)
S. arizonae
Salmonella enterica subsp. arizonae includes around 100 serovars (Grimont and Weill, 2007) and has
a broad host range. It can potentially cause infection, which is usually subclinical, in many species of
birds, such as domestic fowl (Gallus gallus), ducks (Anas platyrhynchos), turkeys (Meleagris gallapavo),
geese (Anser anser), quail (Coturnix japonica), guinea fowl (Numida meleagris) and pheasants
(Phasianus colchicus) (Oros et al., 1998; Shivaprasad, 2008), and reptiles (K€ob€olkuti et al., 2008;
Clancy et al., 2016). It should be noted that many ‘Arizona’ group isolates from reptiles and birds may be
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of the biphasic diarizonae subspecies of Salmonella enterica (Hall and Rowe, 1992; K€ob€olkuti et al., 2008;
Yong et al., 2008; Lukac et al., 2015; Clancy et al., 2016).
S. Gallinarum
Order Galliformes (Chappell et al., 2009); natural outbreaks of fowl typhoid (FT; S. Gallinarum)
have been reported in sparrows, parrots, ring-necked doves, ostriches and peafowl (Harbourne, 1955).
Clinical outbreaks among species other than chickens and turkeys are uncommon (Shivaprasad, 2000).
Individual cases of disease have occasionally been reported in free-ranging game birds, such as
partridges (Shivaprasad and Barrow, 2008).
S. Pullorum
Order Galliformes (Chappell et al., 2009); there are reports of naturally occurring infection in many
bird species, although most cases are traced to some contact with chickens (Bullis, 1977). Natural
outbreaks of Pullorum disease have been reported in quail, sparrows, parrots, canaries and bullﬁnch
(Shivaprasad and Barrow, 2008), although clinical disease is unusual among species other than
chickens, turkey and pheasants (Spickler, 2009).
Parameter 2 – Naturally susceptible domestic species (or family/orders)
S. arizonae
Turkey (Meleagridis gallopavo) is the principal species for infection with serovars O18:Z4,Z23 and
O18:Z4,Z32 (Weiss et al., 1986; Hall and Rowe, 1992; Hafez, 2013). Other domestic poultry, including
chickens (Gallus gallus) and ducks may occasionally show disease (Bigland and Quon, 1958; Silva
et al., 1980), but economic effects are minor other than in turkey production. Arizonae serovars may
be found in animal feed that has been contaminated by reptile faeces and may thereby be occasionally
transmitted to domestic animals, especially laying hens that are fed on non-heat-treated feed, usually
causing a transient subclinical infection.
S. Gallinarum
Order Galliformes; principal clinically affected species are chickens (Gallus gallus) (Bullis, 1977;
Shivaprasad et al., 2013) and turkeys (Meleagris gallopavo) (Hafez, 2013), also pheasants, quail,
guinea fowl, peafowl (Moore, 1946; AHVLA, 2008; Ravishankar et al., 2008; Macovei et al., 2010;
Casagrande et al., 2014). Signiﬁcant clinical outbreaks are uncommon apart from among chickens,
turkeys and pheasants (Shivaprasad, 2000).
S. Pullorum
Order Galliformes; the principal host species is domestic chickens (Gallus gallus). Infection of
turkeys (Meleagris gallopavo) is reported to follow contact with chickens in many cases (Shivaprasad
and Barrow, 2008). Outbreaks in pheasants and guinea fowl are also reported (Hafez, 2013).
Parameter 3 – Experimentally susceptible wildlife species (or family/orders)
S. arizonae
Experimental infection of wildlife species with the turkey-associated O18 serovars is not reported.
S. Gallinarum
Corvids (rooks and jackdaws) manifested clinical disease with mortality following exposure by
various routes (Harbourne, 1955). Pigeons appeared resistant to clinical disease following oral or
parenteral exposure (Aydin et al., 1978).
S. Pullorum
S. Pullorum shows low virulence via the oral route in mice, and is cleared rapidly from systemic
tissues after parenteral inoculation (Barrow, 1994).
Parameter 4 – Experimentally susceptible domestic species (or family/orders)
S. arizonae
Experimental infection of chicks with the turkey-associated O18 serovars has been reported
(Youssef and Geissler, 1979; Silva et al., 1980), demonstrating clinical signs similar to neonatally
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infected turkey poults in a proportion of individuals. Crop inoculation of turkey poults and chicks with
similar doses of turkey Arizona group isolates resulted in more severe disease and mortality in the
turkeys than in the chicks (Hinshaw and McNeil, 1946).
S. Gallinarum
Rabbits showed minor intestinal pathology following oral inoculation, whilst there was systemic
persistence in mice of the same S. Gallinarum strain for over 2 weeks following intravenous inoculation
(Barrow, 1994). However, clinical signs were not seen. Rats orally infected with a high dose (109
colony forming units (CFU)) of S. Gallinarum shed the organism in faeces for up to 121 days (Badi
et al., 1992a). Experimental inoculation of chickens produces outcomes consistent with natural disease
(Barrow, 1994; Berchieri et al., 2001).
S. pullorum
Natural or experimental disease has been reported in various mammalian species: chimpanzee,
rabbit, guinea pig, chinchilla, pig, kitten, fox, dog, pig, mink, cow, rat (Bullis, 1977; Shivaprasad and
Barrow, 2008), although details are sparse. Oral inoculation studies (Barrow et al., 1994) in rabbits,
rats, guinea pigs and mice did not show clinical effects with doses (in the range 107 to 109 cfu) that
caused clinical disease in chicks.
Reservoir animal species
Parameter 5 – Wild reservoir species (or family/orders)
S. arizonae
The relevant serovars are closely associated with turkeys. Wild turkeys are the likely principal wild
reservoir species for turkey-speciﬁc serovars. S. arizonae is primarily carried by reptiles in warm
countries, and these free-living animals can be considered reservoir hosts. Infection of poultry is often
associated with contamination of feed or the production environment by reptile faeces (K€ob€olkuti
et al., 2008; Clancy et al., 2016). Rodents may be an effective short-term reservoir or vector species
on infected premises to facilitate persistence of infection between ﬂocks (Goetz, 1962).
S. Gallinarum
The agent has been isolated from free-living corvids, pigeons, psittacine birds, ducks (Harbourne,
1955; Georgiades and Iordanidis, 2002; Spickler, 2009), chicken-house rats (Aydin et al., 1978; Badi
et al., 1992b), and there is serological evidence of serovar Gallinarum in doves (Espinosa-Arguelles
et al., 2010). Many avian species may be carriers (Barrow et al., 1994; Javed et al., 1994). Shedding
by pigeons appeared to be transient following experimental oral exposure (Aydin et al., 1978). Rats
from area of poultry houses harboured S. Gallinarum in intestines, while experimentally inoculated wild
rats shed S. Gallinarum for 3 months following oral inoculation (Badi et al., 1992a). Red poultry mite
(Dermanyssus gallinae) from infected poultry houses can harbour S. Gallinarum for months, and is the
main route for carry-over between ﬂocks (Zeman et al., 1982; Parmar and Davies, 2007; Ivanics et al.,
2008). Infected red mites can be carried between farms on equipment or the clothing of workers or
visitors, as well as being carried by wild birds moving between farms. Ticks (Argas spp.) also can
harbour the agent but their role in epidemiology is uncertain (Stefanov et al., 1975).
S. Pullorum
The agent has been isolated from several free-living or semiwild avian species, including parrots,
sparrows, quail, peacock, doves, pheasants and pigeons (Javed et al., 1994; Akhter et al., 2010; Hua
et al., 2012), and has been isolated from the intestine of rats on affected fowl premises (Anderson
et al., 2006). In many countries in which S. Pullorum has been eradicated from commercial scale
poultry breeding and production, there remains a reservoir in wild and commercially bred game birds
that are released into the wild for shooting. The regular, sporadic occurrence of Pullorum disease in
hobbyist ﬂocks in developed countries reﬂects the likely persistent presence of a wildlife reservoir
(Shivaprasad and Barrow, 2008; Barrow and Freitas Neto, 2011; OIE, 2012).
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Parameter 6 – Domestic reservoir species (or family/orders)
S. arizonae
Adult turkeys exhibit asymptomatic intestinal carriage and faecal shedding for extended periods
(Shivaprasad, 2008). Historically, small numbers of isolates of the relevant serovars have been
reported from other species, including dogs and sheep in the USA (Weiss et al., 1986), although the
signiﬁcance of this in respect of reservoir status is unknown and there are no recent supporting
reports.
S. Gallinarum
Domestic waterfowl (ducks, geese) appear to be largely resistant to clinical disease (Moore, 1946;
Barrow et al., 1999; Shivaprasad, 2000), but can harbour the agent (Adzitey et al., 2012). It is thought
that small backyard ﬂocks of domestic fowl, which may never be subject to diagnostic investigations,
represent an important reservoir of infection. Isolation of the agent has been reported from apparently
asymptomatic commercially farmed chickens (4% of cloacal swab or faeces samples) in Bangladesh
(Parvej et al., 2016).
S. Pullorum
Domestic waterfowl (ducks, geese) appear to be largely resistant to clinical disease (Shivaprasad
and Barrow, 2008), but can harbour the agent (Anderson et al., 2006; Hua et al., 2012). Isolation of
the agent has been reported from apparently asymptomatic commercially farmed chickens (3.3% of
cloacal swab or faeces samples) in Bangladesh (Parvej et al., 2016).
3.1.1.2. Article 7(a)(ii) The morbidity and mortality rates of the disease in animal
populations
Morbidity
Parameter 1 – Prevalence/incidence
S. arizonae
Disease in turkeys is conﬁned to the ﬁrst few weeks of life and morbidity is highly variable,
reﬂected in quoted mortality ﬁgures of 3.5–90% (Hafez, 2013).
Nineteen serotypes of S. arizonae were isolated from 6,577 samples collected from 371 different
poultry houses of broilers in north-western Spain between 2011 and 2015 and prevalence in the
sample was 0.29% (Lamas et al., 2016).
S. Gallinarum
Morbidity and mortality are highly variable owing to effects of age, ﬂock management, nutrition,
stressors such as travel, other diseases, and variation between breeds of the primary (chicken) host
(Shivaprasad, 2000; Freitas Neto et al., 2007; Chappell et al., 2009; Barrow and Freitas Neto, 2011).
In respect of the last point, median parenteral lethal dose varies over a 107-fold range between inbred
resistant and susceptible chicken breeds, likely mediated by features of the host’s reticuloendothelial
system (Barrow et al., 1994; Barrow and Freitas Neto, 2011). Brown egg-layers are known to be more
susceptible than white egg-layers (Barrow and Freitas Neto, 2011). Experimentally, 60% morbidity was
reported in outbred chickens (Chappell et al., 2009). Among Indian broiler ﬂocks, there was a
morbidity of approximately 10–15% in recent reports (Arora et al., 2015).
S. Pullorum
Morbidity (and mortality) are highly variable owing to effects of age (younger birds are more
susceptible, unlike fowl typhoid), ﬂock management, nutrition, stressors such as travel, other diseases,
and variation between breeds of the primary (chicken) host (Freitas Neto et al., 2007; Shivaprasad and
Barrow, 2008; Chappell et al., 2009; Barrow and Freitas Neto, 2011). Brown egg-layers are known to
be more susceptible than white egg-layers (Barrow and Freitas Neto, 2011). There is a clear age
effect, with older growing and mature fowl often not exhibiting clinical signs, although (depending on
other factors including breed susceptibility) acute disease may be seen in older fowl on some
occasions and egg production and hatchability of eggs is usually affected (Shivaprasad and Barrow,
2008; OIE, 2012). Infected adult turkeys usually show no clinical signs (Hafez, 2013).
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Parameter 2 – Case-morbidity rate (% clinically diseased animals out of infected ones)
S. arizonae
Accurate ﬁgures are not available for this.
S. Gallinarum
Accurate ﬁgures are not available for this. Given the breed-associated variation in susceptibility, the
case-morbidity rate is likely to vary substantially.
S. Pullorum
Accurate ﬁgures are not available for this. Given the breed- and age-associated variation in
susceptibility, the case-morbidity rate is likely to vary substantially (OIE, 2012).
Mortality
Parameter 3 – Case-fatality rate
S. arizonae
Mortality among poultry is variable. Although mortality may reach 90%, more commonly mortality
is up to 15%, being highest in the ﬁrst three weeks and continuing up to ﬁve weeks of age
(Shivaprasad, 2008; Hafez, 2013).
S. Gallinarum
Classically, a high mortality is described for fowl typhoid (Shivaprasad et al., 2013), with a reported
range of 10–93% of chicks infected at or around hatching (Shivaprasad and Barrow, 2008), although
most outbreaks of severe clinical disease occur in adult laying or breeding birds, during the laying
period. The case-fatality rate was consistently around 70% in recent outbreaks (2005–2013) among
broiler chicks in India (Arora et al., 2015). However, again management, age, etc., affect outcomes
and the morbidity rate is often much higher than mortality (Shivaprasad and Barrow, 2008). In a
typical outbreak in a large cage laying ﬂock, mortality can eventually reach 90%, with only isolated
birds that carry genetic resistance remaining alive (Davies, 2016). In naturally infected birds, the
outcome of the infection is marked by high morbidity and up to 80% mortality (Shivaprasad, 2000).
In affected turkey ﬂocks, initial mortality is usually substantial, up to about 25%, and there is a
tendency for intermittent recurrence of clinical disease over 2–3 weeks, with lower mortality during
this phase (Hafez, 2013). Losses typically are lower on premises after the ﬁrst outbreak of disease
(Shivaprasad and Barrow, 2008).
Experimentally, the speed and degree of mortality was highly dose-dependent among 4-day-old
chicks, ranging from 4% to 84% over 28 days post-inoculation (Berchieri et al., 2001). Oral median
lethal doses for chickens of 104 and 105.2 CFU have been claimed (Berchieri et al., 2001; Barrow and
Freitas Neto, 2011).
S. Pullorum
Classically, a high mortality is described for Pullorum disease in young chickens and turkeys (Hafez,
2013; Shivaprasad et al., 2013), with up to 100% of chicks, and poults dying when infected at or around
hatching (Shivaprasad and Barrow, 2008). Highest losses usually occur during the second week after
hatching, with a rapid decline in case mortality between the third and fourth weeks of age. However,
again management, age, etc., affect outcomes and the morbidity rate under commercial conditions is
often much higher than mortality, which can be as low as 0% (Shivaprasad and Barrow, 2008).
Experimentally, oral inoculation of 1-day-old chicks and turkey poults with a virulent turkey-associated
S. Pullorum strain resulted in mortality among turkey groups of 42–78%, peaking at 6–11 days post-
inoculation; among chicken groups mortality was 66–75%, peaking at 13–22 days post-inoculation
(Gwatkin, 1948). By contrast, oral inoculation of slightly older (4-day-old) layer chicks with 109 cfu of an
unrelated S. Pullorum strain resulted in no acute disease or mortality (Berchieri et al., 2001).
AHVLA received intestinal swabs were from 10-day-old pheasant poults of which 100 had died out
of 1,000 birds placed. (http://www.thepoultrysite.com/search/?cat=0&q=Salmonella+pullorum&x=
9&y=8 Accessed 15/06/2017, AHVLA: Salmonella Pullorum in Gamebirds 29 July 2011).
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3.1.1.3. Article 7(a)(iii) The zoonotic character of the disease
Presence
Parameter 1 – Report of zoonotic human cases (anywhere)
S. arizonae
Human disease associated with turkey serovars (O18:Z4,Z23 and O18:Z4,Z32) does not appear to
have been reported in any detail (Shivaprasad, 2008). Isolates of these serovars have been reported from
humans in the USA (Weiss et al., 1986), including 222 between 2003 and 2013 (CDC, 2016); these are
unexpectedly high numbers and it is not clear whether these were associated with disease. It seems
likely, given the data source, that at least some of these isolates were from individuals showing symptoms
of illness warranting sampling and culture. Human infections with O18:Z4,Z23 and O18:Z4,Z32 were
described among Latin Americans in California in the 1980s, and in the same report a link was identiﬁed
between human arizonosis associated with other serovars and the consumption of reptile-associated folk
medicines (Waterman et al., 1990). It is possible the O18 serovars are acquired in many cases by a
similar route. There are numerous reports of human arizonosis, caused by other serovars, typically in
association with reptiles or travel (Hall and Rowe, 1992; Shivaprasad, 2008; Di Bella et al., 2011; Gunal
and Erdem, 2014). Gastroenteritis and systemic infections have been reported.
S. Gallinarum
Being avian host-adapted, S. Gallinarum poses minimal zoonotic risk (Eswarappa et al., 2009; OIE,
2012). Just 13 of around 391,000 human Salmonella isolations from the US Centers for Disease
Control and Prevention between 1996 and 2006 were reported as S. Gallinarum/Pullorum (CDC, 2008);
in the period 2003–2013 the equivalent proportion was zero, from 462,000.
S. Pullorum
Being avian host-adapted, S. Pullorum poses a very low zoonotic risk (Shivaprasad, 2000; OIE,
2012). Historical case reports in the literature indicate S. Pullorum can induce an acute, self-limiting
enteritis after consuming highly contaminated food, typically infected eggs (Mitchell et al., 1946;
Shivaprasad, 2000). More prolonged gastroenteritis was attributed to S. Pullorum in one case, but the
immune status of the patient is unclear (Judeﬁnd, 1947).
3.1.1.4. Article 7(a)(iv) The resistance to treatments, including antimicrobial resistance
Parameter 1 – Resistant strain to any treatment even at laboratory level
S. arizonae
The agent is not known to be resistant to antibiotics, but data on incidence and trends in resistance
is scarce as the organism has not been reported in recent years.
S. Gallinarum/S. Pullorum
Clinical disease and losses can be suppressed by antibiotic treatment (Ravishankar et al., 2008; Barrow
and Freitas Neto, 2011). Infection cannot be eliminated from ﬂocks by use of antimicrobials (Georgiades
and Iordanidis, 2002; Ravishankar et al., 2008; Barrow and Freitas Neto, 2011). Antibiotic resistances
appear to reﬂect prevailing regional patterns of antibiotic usage and clonal dissemination of strains and
reﬂects trends amongst Salmonella enterica isolates from poultry more generally (Javed et al., 1994;
Georgiades and Iordanidis, 2002; Kumar et al., 2012; Agada et al., 2014). There is evidence, from survey
and surveillance data, of increasing antimicrobial resistance over time (Zeman et al., 1982; Lee et al., 2003;
Ivanics et al., 2008; Ravishankar et al., 2008; Barrow and Freitas Neto, 2011; Filho et al., 2016).
3.1.1.5. Article 7(a)(v) The persistence of the disease in an animal population or the
environment
Animal population
Parameter 1 – Duration of infectious period in animals
S. arizonae
Acute disease with mortality in young turkeys has a duration typically of 3–5 weeks, but older
animals may carry the agent in the intestinal tract and shed it chronically (Shivaprasad, 2008).
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S. Gallinarum
Shedding in the faeces was reported during clinical disease ‘and into the stage of convalescence’
(Gauger, 1937). A more recent oral inoculation study, using relatively susceptible 18-week brown laying
hens, showed a minority of hens to have positive caecal contents at each of 3, 7, 14 and 21 days post-
inoculation (Oliveira et al., 2005). In the same report, other studies showed shedding usually occurred
in the days shortly before death, from 7 to 28 days post-inoculation, or for one or more days from 11
to 27 days post-inoculation among those birds that survived.
S. Pullorum
There are no reliable data on the acute infectious period of chickens and turkeys. S. Pullorum
colonises the gut poorly in the absence of clinical disease (Barrow and Freitas Neto, 2011), although
experimentally, S. Pullorum-positive cloacal swabs were obtained from a minority of young and old
hens at ﬁve weeks post-inoculation (Berchieri et al., 2001).
Parameter 2 – Presence and duration of latent infection period
S. arizonae
Since most infection in clinical cases is believed to be present at hatching, either through
transovarian infection or pseudovertical transmission via shell penetration from faecal contamination,
there may effectively be no latent period for newly hatched poultry. The agent readily colonises the
intestinal tract of older birds, therefore faecal shedding is likely to start within a few hours of exposure
(Shivaprasad, 2008). Experimentally in chicks, shedding of the agent was observed 24 h after oral or
subcutaneous inoculation (Youssef and Geissler, 1979).
S. Gallinarum
Latency for shedding in droppings appeared to be around 7 days in a susceptible breed of laying
hens, although transmission by contact with dead birds, also from around 7 days post-inoculation,
appeared to be the more signiﬁcant route as prompt removal of dead hens greatly reduced spread
(Oliveira et al., 2005). Similarly, commercial layer hens inoculated orally yielded S. Gallinarum from
cloacal swabs taken 1 week later (Berchieri et al., 2001). Latency before tissue or cloacal isolation
following oral inoculation of mature laying hens of a relatively resistant phenotype was 3 days;
S. Gallinarum was isolated from tissue but not cloaca/caecum after this, up to 4 weeks (Berchieri
Junior et al., 2000).
S. Pullorum
No published data was found regarding latency of shedding. As the agent is shed during the acute
phase of disease (Barrow and Freitas Neto, 2011; OIE, 2012), it is reasonable to postulate that
shedding starts before or at the onset of clinical signs, which may be as early as 3 days post-exposure
in birds that are not infected in ovo (Hafez, 2013).
Parameter 3 – Presence and duration of the pathogen in healthy carriers
S. arizonae
Asymptomatic colonisation and shedding is the normal mode of intestinal carriage in adult turkeys,
which may be long-lived. Systemic infection also occurs, leading to colonisation of reproductive tissues
ovaries, oviducts, and stag testes and semen (Shivaprasad, 2008). Chicks (Gallus gallus) infected orally
with a turkey serovar shed the agent for up to 49 days, after showing transient depression and
inappetence (Youssef and Geissler, 1979).
S. Gallinarum
Intestinal carriage in chickens without overt disease appears to be common in areas where the
disease is endemic: 23% of droppings cultured from Nigerian commercial poultry premises and 19% of
cloacal swabs from Bangladeshi laying farms yielded the organism (Rahman et al., 2011; Agada et al.,
2014). A lower frequency of detection (4% of samples) was reported in another Bangladeshi study of
commercial ﬂocks (Parvej et al., 2016). S. Gallinarum was isolated from the pharynx of seven fatal and
eight carrier ﬁeld cases for a few days to several months after the onset of clinical disease (Gauger,
1937). Birds surviving an outbreak may be asymptomatic carriers of the agent in reproductive tissues,
but the incidence is uncertain.
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S. Pullorum
Intestinal carriage may occur in chickens without overt disease: 3.3% of droppings cultured from
Nigerian commercial poultry premises and 27% of cloacal swabs from Bangladeshi laying farms yielded
the organism (Rahman et al., 2011; Agada et al., 2014). Isolation from 3.3% of cloacal or droppings
samples was reported in another Bangladeshi study of commercial ﬂocks (Parvej et al., 2016).
Systemic carriage of the agent by asymptomatic and recovered birds is a major issue. Following
infection, in a proportion of birds S. Pullorum will persist in liver and spleen for 50 weeks or more,
multiplying and spreading to the reproductive tract tissues in female birds at the time of sexual
maturity (Gwatkin, 1948; Wigley et al., 2005; Chappell et al., 2009).
Environment
Parameter 4 – Length of survival (dpi) of the agent and/or detection of DNA in selected matrices (soil,
water, air) from the environment (scenarios: high and low T)
S. arizonae
Survival is reported for up to 5 months in contaminated water, up to 17 months in feed, and
6–7 months in soil on turkey units (Shivaprasad, 2008). Survival characteristics appear similar to other
Salmonellae, and Table 1 provides details of some of the documented survival times for Salmonella in
various environments.
S. Gallinarum
Survival for several years in favourable environments is claimed (Shivaprasad and Barrow, 2008).
However, in poultry faeces inside and outdoors, survival times of up to 37 and 31 days, respectively,
were noted experimentally for S. Gallinarum (Smith, 1955). Table 1 provides details of some of the
documented survival times for Salmonella in various environments. These are likely to be the upper
limit of values for S. Gallinarum, as it appears to be less hardy than many other serovars (Shivaprasad,
2000). Survival of S. Gallinarum in dormant red mites can be prolonged (at least 7 months) and can
result in infection of birds placed in houses containing dormant mites (Zeman et al., 1982; Parmar and
Davies, 2007; Ivanics et al., 2008).
Table 1: Survival of Salmonella spp. in various environments (adapted from Mitscherlich and Marth,
1984)
Matrix Serovar Conditions Initial count Survival Comments
Egg, fresh
whole
Enteritidis 4°C and 25°C Approx. 107 CFU 4°C: > 270, < 365 days
25°C: > 365 days
Typhimurium 4°C and 25°C Approx. 107 CFU 4°C: > 180, < 270 days
25°C: > 365 days
Egg, whole† (Pullorum) 25°C 9 months
Egg
surface‡
(Pullorum) Room
temperature,
ambient humidity
6 9 107 cfu.mL1
contaminating
suspension
Clean shell: 21 days
Dirty shell (10% sterile
hen faeces in S. Pullorum
suspension): > 21 days
No change in
recovery rate from
dirty shell eggs
over 21 days
Faeces,
poultry
Typhimurium Fresh, 19°C
(pH 8.9) and
5–8.9°C
(pH 8.1–8.9)
108 CFU/mL 19°C: < 6 days.
5°C–8.9°C: > 12,
< 25 days
Salmonella-
impregnated silk
immersed in
faeces
Faeces,
rodent*
148 days
Hatchery
chick ﬂuff
Senftenberg Room
temperature
Natural
contamination
≥ 1484 days Stored in
polythene bags
Pasture Typhimurium Summer, New
Zealand
2 9 107 CFU 25/
cm2
> 70, < 84 days Applied in faecal
suspension
Sweeper
dust*
300 days
aw: water activity; CFU: colony forming units.
Data abstracted from Mitscherlich and Marth (1984), except *Jones (2011), †Stafseth et al. (1952) and ‡Lancaster and Crabb (1953).
AHL assessment on Salmonella infection in poultry (S. Pullorum, S. Gallinarum, S. arizonae)
www.efsa.europa.eu/efsajournal 11 EFSA Journal 2017;15(8):4954
S. Pullorum
Survival for several years in favourable environments is claimed (Shivaprasad and Barrow, 2008).
However, in poultry faeces inside and outdoors, survival times of up to 37 and 31 days, respectively,
were noted experimentally for S. Gallinarum biovar Gallinarum (Smith, 1955). Extended survival of
S. Pullorum (no reduction in frequency of recovery over 3 weeks) was noted experimentally on the
surface of eggs when sterilised chicken faeces were also present (Lancaster and Crabb, 1953). Table 1
provides details of some of the documented survival times for Salmonella in various environments, but
S. Pullorum is considered to survive poorly outside the host, compared to most other serovars that are
adapted to the intestine rather than systemic carriage (Shivaprasad, 2000).
3.1.1.6. Article 7(a)(vi) The routes and speed of transmission of the disease between
animals, and, when relevant, between animals and humans
Routes of transmission
Parameter 1 – Types of routes of transmission from animal to animal (horizontal, vertical)
S. arizonae
Infection of hatching turkey poults is considered to be a consequence of vertical infection resulting
from chronic infection of the reproductive tract tissues of parent birds and horizontal spread between
newly hatched poults while still in the hatcher cabinets or during subsequent processing and
transportation (Hinshaw and McNeil, 1946; Goetz, 1962; Crespo et al., 2004). There may also be
trans-shell infection as a consequence of faeces contamination from shedding adult turkeys
(Shivaprasad, 2008), but this is likely to be limited under ﬁeld conditions unless faecally soiled eggs are
hatched and no egg sanitisation is carried out prior to hatching. Horizontal transmission is likely
between older birds, given the propensity of the agent for enteric colonisation and shedding.
S. Gallinarum
Horizontal transmission is considered to be the more common route in fowl typhoid (FT) (Barrow
and Freitas Neto, 2011). Transmission within a ﬂock was strongly enhanced when dead birds were left
in situ for 48 h, indicating that horizontal transmission from carcases may be substantial (Oliveira
et al., 2005). This may involve movement of red mites from dead to live birds. Quoted routes include
cannibalism, wounds, eating eggs, faeces, feed, water, litter, human and wildlife vectors (Shivaprasad
and Barrow, 2008). Recent experiments have failed to document egg contamination in chickens, or of
survival of S. Gallinarum in artiﬁcially inoculated eggs (Berchieri et al., 2001; Oliveira et al., 2005).
Nonetheless, some older studies did show egg contamination (Barrow and Freitas Neto, 2011),
reproductive tract tissues are commonly culture-positive in carrier birds and vertical transmission is still
considered to be a potentially important route of transmission (Barrow and Freitas Neto, 2011; OIE,
2012), particularly in turkeys where there is reportedly a predilection for infection of reproductive
organs in adult carriers (Hafez, 2013). Field sampling has also indicated roles for rodent and
invertebrate vectors, especially for blood-sucking arthropod parasites such as red poultry mite (Aydin
et al., 1978; Badi et al., 1992b; Parmar and Davies, 2007; Ivanics et al., 2008; Spickler, 2009).
S. Pullorum
Vertical transmission is considered to be a crucial route for propagation and persistence of
S. Pullorum in chickens and turkeys although horizontal transmission, particularly in incubators around
the time of hatching, is signiﬁcant for the extent and severity of disease (Mallmann and Moore, 1936;
Gwatkin, 1945; Bullis, 1977; Barrow and Freitas Neto, 2011; Hafez, 2013). Transmission through shell
penetration may have a minor role. On farms, quoted routes for horizontal transmission include
introduction of infected birds into a holding, cannibalism, wounds, eating eggs, poultry faeces, feed,
water, litter, human and wildlife mechanical vectors (Shivaprasad and Barrow, 2008).
Parameter 2 – Types of routes of transmission between animals and humans (direct, indirect, including
food-borne)
S. arizonae
The relevant serovars (O18:Z4,Z23 and O18:Z4,Z32) have historically been isolated from various
human foodstuffs (Weiss et al., 1986; Hall and Rowe, 1992), although evidence is lacking on the
matter of transmission between poultry and humans of S. enterica arizonae (Shivaprasad, 2008).
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S. Gallinarum
There are no ﬁrm data on routes of transmission between affected birds and humans. As egg
infection does not appear to be common in FT, any food-borne transmission may be via carcasses of
infected birds, although there are very few reports of any human disease. In respect of possible direct
transmission, none of 90 faeces samples from poultry farm workers in an endemically affected area
(Nigeria) yielded S. Gallinarum (Agada et al., 2014).
S. Pullorum
The historical case reports indicate food sources, particularly eggs (Mitchell et al., 1946; Judeﬁnd,
1947). In respect of possible direct transmission, none of 90 faeces samples from poultry farm workers
in an endemically affected area (Nigeria) yielded S. Pullorum (Agada et al., 2014).
Speed of transmission
Parameter 3 – Incidence between animals and, when relevant, between animals and humans
S. arizonae
It is not established if there is any signiﬁcant transmission between young turkey poults during the
clinical disease phase. It is possible that all clinical disease results from infection in ovo.
S. Gallinarum
The classical pattern of clinical disease is of outbreaks, with rapid spread and high morbidity and
mortality. This may, however, be slowed down by the use of S. enteritidis vaccine in laying and
breeding ﬂocks, leading to a gradual increase in mortality followed by an explosive outbreak as
infection pressure exceeds vaccine protection. Incubation of the disease is typically 4–6 days, and
death usually occurs 5–10 days after exposure (Shivaprasad, 2000; Spickler, 2009). Among turkeys,
initial losses may extend over 2–3 weeks and there may be intermittent recurrence (Hafez, 2013).
Disease may occur at and shortly after hatching, or acute and subacute disease can be seen among
older animals, with carryover between ﬂocks after repopulation (Cobb et al., 2005; Ivanics et al.,
2008). Thus, transmission between animals occurs, by direct and indirect routes. It can be rapid
enough to generate and sustain an outbreak with morbidity and mortality up to 61% via close contact,
such as in hatchers (Shivaprasad and Barrow, 2008), and it can also occur over a longer timescale,
causing recurrent or chronic disease patterns.
S. Pullorum
The classical pattern of clinical disease is of outbreaks in young birds, with a proportion of diseased
and moribund chicks or turkey poults at hatching, rapid horizontal spread and high morbidity and
mortality peaking during the second or third weeks of life, although in some cases disease may not be
evident in the batch or ﬂock until ﬁve to ten days after hatching (Shivaprasad and Barrow, 2008;
Hafez, 2013).
The extent to which infection in newly hatched chicks results from vertical versus horizontal
transmission is uncertain, although experimentally only a minority of eggs or chicks from infected hens
have proved to harbour the agent (Mallmann and Moore, 1936; Berchieri et al., 2001). Therefore, it
appears likely that transmission between newly hatched chicks can be rapid enough to generate and
sustain an outbreak with high morbidity and mortality, peaking at two to three weeks of age. Vertical
transmission, by its nature, occurs over a longer timescale.
Parameter 4 – Transmission rate (beta) (from R0 and infectious period) between animals and, when
relevant, between animals and humans
S. arizonae
There are no data published on transmission rate between birds during clinical or asymptomatic
infection.
S. Gallinarum
There are no ﬁrm data published on transmission rate, and the known variations in species, age
and breed susceptibilities, plus dose effects, suggest that the transmission rate is likely to be highly
variable according to circumstances. In a typical outbreak in a large cage laying ﬂock, mortality
increases gradually within speciﬁc cages that are close to the point of introduction of infection into the
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house. After a few days, there is a dramatic extension of mortality to other cages within the same
stack and then, within 2–3 days, to other stacks (OIE, 2012).
S. Pullorum
There are no ﬁrm data published on transmission rate, and the known variations in species, age
and breed susceptibilities, plus dose effects, suggest that the transmission rate is likely to be highly
variable according to circumstances.
3.1.1.7. Article 7(a)(vii) The absence or presence and distribution of the disease in the
Union, where the disease is not present in the Union, the risk of its introduction
into the Union
Presence and distribution
Parameter 2 – Type of epidemiological occurrence (sporadic, epidemic, endemic) at MS level
S. arizonae
The serovars of signiﬁcance appear to have been largely or completely eradicated from European
turkey production (EFSA, 2008; EFSA BIOHAZ Panel, 2012).
S. Gallinarum
Sporadic; since 2005, there have been outbreaks reported in single years, or up to four-year
periods, in domestic ﬂocks in Belgium, Bulgaria, France, Germany, Hungary, Italy, the Netherlands and
the UK. In Romania, the disease has been reported in all years to 2012, and the presence of the agent
was reported in 2014–2016 (OIE, 2016c). The UK reports from 2005 have detailed up to three
incidents a year in pheasants, and zero to six incidents a year in backyard poultry and large
commercial laying ﬂocks between 2002 and 2012 (AHVLA, 2008; Northern Ireland disease surveillance
report, 2012; AHVLA, 2015).
S. Pullorum
Sporadic; since 2005, the disease has been reported in single- or up to six-year periods in domestic
ﬂocks in the Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, the Netherlands,
Norway, Poland, Romania and the UK (APHA, 2016). The UK reports from 2011 have detailed up to two
incidents a year in pheasants and zero to three isolations a year from backyard poultry (OIE, 2016c).
Risk of introduction
Parameter 3 – Routes of possible introduction
S. arizonae
Potential routes include international trade in hatching eggs, chicks or breeding poultry, spread
within territories from asymptomatic non-commercial poultry or wild and semiwild birds (pheasants,
waterfowl, etc.) import of contaminated poultry meat, import of other animals carrying the agent.
S. Gallinarum
Potential routes include international trade in hatching eggs, chicks or breeding poultry, spread
within territories from asymptomatic non-commercial poultry or wild and semiwild birds (pheasants,
waterfowl, etc.).
S. Pullorum
Potential routes include international trade in hatching eggs, chicks or breeding poultry, spread
within territories from asymptomatic non-commercial poultry, including fancy fowl (via trade and
showing), or wild and semiwild birds (pheasants).
Parameter 4 – Number of animal moving and/or shipment size
S. arizonae
Aggregate of reported live imports of turkeys for all Member States (MS) in 2013: 43,793,000 birds
(FAOstat).
Reported total turkey egg incubations in the European Union (EU) in 2014: 274 million (European
Commission).
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S. Gallinarum/S. Pullorum
Recent aggregated trade ﬁgures are given in Table 2. Some MS’s report zero (or conﬁdential)
ﬁgures for some or all years, and such data is reported by the different MS’s at their discretion. Thus,
under-reporting may be quite common (EFSA, 2009).
Estimates of total hen’s egg incubations (broilers and layer) in EU, using ﬁgures for 2015 (or latest
reported year if not reported in 2015): 9.3 billion.
Reported total turkey egg incubations in EU in 2014: 274 million.
Parameter 5 – Duration of infectious period in animal and/or commodity
S. arizonae
The infectious period in surviving symptomatic birds is not clearly established; prolonged carriage
and shedding is common (Shivaprasad, 2008).
S. Gallinarum
The infectious period in surviving symptomatic birds is not clearly established. Experimentally, faecal
shedding of the agent was inconsistent (Berchieri Junior et al., 2000) and occurred only occasionally,
up to about one month after inoculation of laying hens (Oliveira et al., 2005).
S. Pullorum
The infectious period in surviving symptomatic birds is not clearly established.
Parameter 6 – List of control measures at border (testing, quarantine, etc.)
S. arizonae
Council Directive 2009/158/EC,1 as updated by Commission Implementing Decisions 2011/214/EU
and 2011/879/EU, speciﬁes that, for approval for intra-community trade, turkey establishments
participate in a surveillance programme for relevant Salmonella arizonae serovars. The ISO 6579
(Annex D) method that is used for monitoring zoonotic Salmonella serovars in the EU is also suitable
for detection of the O18 turkey arizonae strains in turkeys that are subject to international trade.
There are no stipulations on imports from third countries.
S. Gallinarum
Council Directive 2009/158/EC as updated by Commission Implementing Decisions 2011/214/EU
and 2011/879/EU, speciﬁes management and risk-based monitoring conditions for breeding ﬂocks and
hatcheries involved in international trade. In addition, for small consignments of imported birds (< 20)
traded internationally within the EU and received from third countries, all birds are to have tested
serologically negative for S. Gallinarum in the preceding month. The ﬂock of origin of hatching eggs or
day-old chicks is to have tested serologically negative for S. Gallinarum in the preceding 3 months, at
a level which gives 95% conﬁdence of detecting infection at 5% prevalence.
The OIE Terrestrial Code (OIE, 2017) recommends that Veterinary Authorities require an
international veterinary certiﬁcate attesting that imported domestic birds showed no clinical sign of FT
on the day of shipment; come from establishments which are recognised as being free from FT;
and/or have been subjected to a diagnostic test for FT and Pullorum disease with negative results;
Table 2: Recent reported intra-EU trade and exports of chicks of Gallus gallus
Class of chick*
Intra-EU trades Exports
2014 2015 2014 2015
Layer producer 60,132,000 45,162,000 16,896,000 18,011,000
Layer breeder 14,354,000 11,219,000 9,720,000 10,146,000
Broiler fattening 535,726,000 493,891,000 106,775,000 109,125,000
Broiler breeder 53,506,000 56,244,000 36,164,000 40,558,000
*: ‘chicks’ means live farmyard poultry the weight of which does not exceed 185 g. Values given are number of individual chicks.
Source of data on trade and egg incubations: EUROSTAT (European Commission).
1 Council Directive 2009/158/EC of 30 November 2009 on animal health conditions governing intra-Community trade in, and
imports from third countries of, poultry and hatching eggs. OJ L 343, 22.12.2009, p. 74–113.
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and/or were kept in a quarantine station for not less than 21 days prior to shipment. Certiﬁcates for
hatching eggs or day-old birds should attest that the sources are recognised as being free from FT and
comply with OIE-deﬁned standards; that eggs and chicks were shipped in clean and unused packages,
and that eggs have been disinfected in accordance with OIE-deﬁned standards.
S. Pullorum
Council Directive 2009/158/EC as updated by Commission Implementing Decisions 2011/214/EU
and 2011/879/EU, speciﬁes management and risk-based monitoring conditions for breeding ﬂocks and
hatcheries involved in international trade. In addition, for small consignments of imported birds (< 20)
traded internationally within the EU and received from third countries, all birds are to have tested
serologically negative for S. Gallinarum in the preceding month. The ﬂock of origin of hatching eggs or
day-old chicks is to have tested serologically negative for S. Gallinarum in the preceding 3 months, at
a level which gives 95% conﬁdence of detecting infection at 5% prevalence (Racicot et al., 2011).
The OIE Terrestrial Code (OIE, 2017) recommends that Veterinary Authorities require an
international veterinary certiﬁcate attesting that imported domestic birds showed no clinical sign of
Pullorum disease on the day of shipment; come from establishments which are recognised as being
free from Pullorum disease; and/or have been subjected to a diagnostic test for Pullorum disease with
negative results; and/or were kept in a quarantine station for not less than 21 days prior to shipment.
Certiﬁcates for hatching eggs or day-old birds should attest that the sources are recognised as being
free from Pullorum disease and comply with OIE-deﬁned standards; that eggs and chicks were shipped
in clean and unused packages, and that eggs have been disinfected in accordance with OIE-deﬁned
standards.
Parameter 7 – Presence and duration of latent infection and/or carrier status
S. arizonae
Asymptomatic colonisation and shedding is the normal mode of intestinal carriage in adult turkeys;
this may be long-lived. Systemic infection also occurs, leading to colonisation of reproductive tissues
ovaries, oviducts, stag testes and semen (Shivaprasad, 2008). Infected eggs may be produced over an
extended period; in excess of 20 weeks in one study (Goetz, 1962; Kumar et al., 1974).
S. Gallinarum
Among recovered or asymptomatic mature stock, it is thought that there may be a number of birds
exhibiting long-term carriage of the agent, with potential to lay infected eggs, although this is a more
obvious feature of biovar Pullorum (Shivaprasad, 2000; Shivaprasad and Barrow, 2008). The proportion
of carriers, and duration of carriage, are not known and may depend on strain of bacterium and genotype
of host. Experimentally, infections of young or in-lay hens were noted either to result in death or
clearance of the agent from the host (Berchieri et al., 2001). However, in an historical study,
S. Gallinarum was isolated from the pharynx of carrier ﬁeld cases for up to several months after the onset
of clinical disease (Gauger, 1937).
S. Pullorum
Among recovered or asymptomatic mature stock there will be a number of birds exhibiting long-
term carriage of the agent, with potential to lay infected eggs (Wigley et al., 2005; Shivaprasad and
Barrow, 2008; Barrow and Freitas Neto, 2011). Systemic carriage has been observed for at least
50 weeks (Gwatkin, 1948; Chappell et al., 2009). In terms of commercial ﬂock infection, this appears
to be the most signiﬁcant mode of latent carriage. However, carriage with shedding in faeces may also
occur in mature stock (Rahman et al., 2011; Agada et al., 2014).
3.1.1.8. Article 7(a)(viii) The existence of diagnostic and disease control tools
Diagnostic tools
Parameter 1 – Existence of diagnostic tools
S. arizonae
Serological monitoring. Rapid serum plate, tube agglutination and microagglutination tests have
been used, with a whole blood antigen test having proven useful in the ﬁeld (Shivaprasad, 2008;
Hafez, 2013). Bacteriological tests of faecal and environmental samples are relatively sensitive, unlike
testing for S. Gallinarum or S. Pullorum and while an enzyme-linked immunosorbent assay (ELISA) was
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developed by Nagaraja (1986) using outer membrane protein as a capture antigen, serological
monitoring is rarely used and no commercial ELISA kits are currently available.
Isolation and identiﬁcation of the agent. Culture techniques for isolation of non-typhoidal
Salmonella from poultry samples and premises are also used to isolate S. enterica arizonae. Bismuth
sulﬁte agar has proved to be a good medium for plating enrichment broths for arizonae in general
(Hafez, 2013), some of which may be lactose fermenters or non-producers of hydrogen sulﬁde on
standard media, but this discrimination is not needed for the O18 turkey arizonae strains. Monitoring
of turkey ﬂocks in the EU should use the Annex D of ISO 6579 method (CEN, 2007).
S. Gallinarum/S. Pullorum
Serological monitoring. Originally developed and reﬁned in the early 20th Century for S. Pullorum
(Bullis, 1977; Hafez, 2013), tests include stained-antigen whole blood and rapid serum agglutination
plate tests, the former being especially suitable for ﬁeld use. Macroscopic tube agglutination and
microagglutination tests are also commonly used (Shivaprasad and Barrow, 2008; OIE, 2012). Other
serological tests have been developed as research and diagnostic tools, with the most commonly
employed approach being ELISA-). No commercial ELISA kits are available.
Isolation and identiﬁcation of the agent. Culture techniques and sampling strategies to optimise
recovery of S. Gallinarum and S. Pullorum are well-established (OIE, 2012), although it is not easy to
isolate the agent from faeces or environmental samples. Aseptically collected ‘dead in shell’ embryos or
tissues from mortalities or serologically positive birds are recommended. There are established
serological and biochemical tests to identify to serovar and biovar level. Additionally, molecular genetic
approaches to identiﬁcation using polymerase chain reaction (PCR) have been developed, although
they are not yet internationally validated (Kang et al., 2011; Zhu et al., 2015).
Control tools
Parameter 2 – Existence of control tools
S. arizonae
The principal control tool for turkey production is the establishment of O18 arizonae-free breeding
ﬂocks. Some inactivated vaccines have been shown to prevent or reduce vertical transmission
(Shivaprasad, 2008; Hafez, 2013), but none are commercially available.
S. Gallinarum/S. Pullorum
Established and validated methods to exclude infection include sourcing eggs/chicks from certiﬁed
FT-clean/Pullorum disease-free ﬂocks; segregating FT-clean/Pullorum disease-free stock from other
poultry and birds; suitable cleaning and disinfection of accommodation; hygienic feed processing,
sound biosecurity (Shivaprasad, 2000). Where infection is present, depopulation or test and remove
policies based on serology are employed.
3.1.2. Article 7(b) The impact of diseases
3.1.2.1. Article 7(b)(i) The impact of the disease on agricultural and aquaculture
production and other parts of the economy
The level of presence of the disease in the Union
Parameter 1 – Number of MSs where the disease is present
S. arizonae
S. enterica arizonae was not detected in a community-wide baseline Salmonella survey of turkey
production conducted in 2006–2007. There is no recent evidence of isolations in EU Trends and
Sources reports, nor in Great Britain Salmonella in Livestock reports.
S. Gallinarum
Nine MS have reported disease in the last 10 years: Belgium, Bulgaria, France, Germany, Hungary,
Italy, the Netherlands, Romania and the UK. In the last complete year (2015), one MS (Italy) reported
disease, one (Romania) reported infection (OIE, 2016c).
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S. Pullorum
Eleven MS reported disease in the last 10 years, but in the last complete year (2015), no MS
reported Pullorum disease (OIE, 2016c).
The loss of production due to the disease
Parameter 2 – Proportion of production losses (%) by epidemic/endemic situation
S. arizonae
In the event of disease outbreak, losses will be substantial as it is likely to involve one or more
breeding ﬂocks, given the nature of transmission. Culling, disinfection and replacement of the affected
ﬂock from clean stock would likely be required.
S. Gallinarum
Losses depend on the level of production in which the infection is present. In non-endemic areas
(e.g. EU), eradication of disease following sporadic outbreaks necessitates testing, culling (100% loss)
and replacement of any affected breeding ﬂock. Test and remove strategies are generally not viable
for production ﬂocks, owing to the high mortality experienced in a FT outbreak.
S. Pullorum
Losses depend on the level of production in which the infection is present. In non-endemic areas
(e.g. EU), eradication of disease following sporadic outbreaks necessitates testing, culling (100% loss)
and replacement of any affected breeding ﬂock. Grower/laying ﬂocks require testing and culling with
replacement where positive, or repeat testing with removal of reactors. Percent losses in the latter
case will be variable, but labour and technical costs of serological testing will be substantial.
3.1.2.2. Article 7(b)(ii) The impact of the disease on human health
Transmissibility between animals and humans
Parameter 1 – Types of routes of transmission between animals and humans
S. arizonae
Transmission of turkey O18 arizonae strains to humans is not an established phenomenon, although
isolation of the relevant serovars from human sources is regularly (but not commonly) reported in the
USA (CDC, 2016).
S. Gallinarum
In the absence of evidence relating to the very small reported number of possible cases of human
disease, any routes of transmission between animals and humans are speculative. S. Gallinarum was
isolated from table eggs in Germany and Italy in 2004 (EFSA, 2005).
S. Pullorum
Only food-borne routes of transmission have been reported.
Parameter 2 – Incidence of zoonotic cases
S. arizonae
Reports of human cases of arizonosis have not been associated with the serotypes that cause
disease in the turkey industry.
S. Gallinarum
There are two cases of human septicaemia and one of human empyema attributed to S. Gallinarum
in the literature, all in individuals in the Middle East, and without evidence of immunodeﬁciency
(Yousuf et al., 2001; Shariﬁ-Mood et al., 2006). The septicaemic cases had recent histories of
vaccination with killed Typhoid vaccine, whilst the empyema case had a history of treatment for
tuberculosis. Clinical S. Gallinarum infection in humans is extremely rare, and it is possible that in the
existing case reports one or more isolates (for example non-motile S. Enteritidis) were misidentiﬁed,
having been isolated in non-veterinary laboratories.
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S. Pullorum
The reported cases and outbreaks are historical; many are attributed to eggs and occurred in the
time before S. Pullorum was eradicated from commercial laying ﬂocks in developed nations (Mitchell
et al., 1946; Judeﬁnd, 1947; Tanev et al., 1964).
Transmissibility between humans
Parameter 3 – Human to human transmission is sufﬁcient to sustain sporadic cases or community-level
outbreak
S. arizonae
There is no published, or otherwise available, data that indicates human to human transmission of
turkey serovars.
S. Gallinarum
There is no evidence of human to human transmission.
S. Pullorum
There is no evidence of human to human transmission. An historical experimental study reported
that oral doses around 109–1010 cfu were required to elicit clinical symptoms in volunteers, and that
with lower doses there was no evidence of faecal shedding (McCullough and Eisele, 1951).
Parameter 4 – Sporadic, endemic or pandemic potential
S. arizonae
Very low potential for disease with turkey serovars.
S. Gallinarum
Human disease, if it exists, is sporadic and rare.
S. Pullorum
Human disease is sporadic and rare.
The severity of human forms of the disease
Parameter 5 – Disability-adjusted life year (DALY)
S. arizonae
The principal source of data on human isolates of turkey-associated serovars are the US Centers for
Disease Control and Prevention (CDC, 2008, 2016). Clinical details are not collected or reported. One
summary, using US data to 1976, reported that O18:Z4,Z23 human infections were associated primarily
with extraintestinal sources, whereas serovar O18:Z4,Z32 showed an extraintestinal to intestinal source
ratio (0.44) that was similar to arizonae isolates generally (Weiss et al., 1986). Both serovars were reported
as blood isolates in some cases, suggesting the potential for systemic infection in certain individuals.
S. Gallinarum
The very few reported human cases had severe illness, but this may be subject to reporting bias.
S. Pullorum
The reported human cases typically had fever, with variable other symptoms such as diarrhoea and
headache. Where described, clinical effects were typically of short (2–3 days) duration. Long-term
sequelae were not reported.
The availability of effective prevention or medical treatment in humans
Parameter 6 – Availability of medical treatment and their effectiveness (therapeutic effect and any
resistance)
S. arizonae
Published descriptions of the treatment of human arizonosis do not include turkey-associated
serovars. Patients with systemic arizonosis of other (or undetermined) serovars have been reported to
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recover following therapy with suitable antibiotics (Di Bella et al., 2011; Gunal and Erdem, 2014).
Commonly, human cases of arizonosis have co-morbidities or risk factors that may predispose to
infection and, in some cases, may complicate treatment (Waterman et al., 1990; Hall and Rowe, 1992;
Di Bella et al., 2011).
S. Gallinarum
Treatment of the three reported human cases with antibiotic combinations guided by culture and
sensitivity results, plus other appropriate interventional and supportive treatments, led to resolution of
the clinical condition in all cases.
S. Pullorum
Treatment of clinical cases would likely involve supportive care for enteritis, plus antibiotic
treatment if systemic involvement was evident or suspected, for example in an immunocompromised
patient. Treatment would not be expected to depart substantially from contemporary treatments for
salmonellosis caused by other serovars.
Parameter 7 – Availability of vaccines and their effectiveness (reduced morbidity)
S. arizonae
There are no human vaccines speciﬁcally for arizonosis.
S. Gallinarum/S. Pullorum
There are no human vaccines.
3.1.2.3. Article 7(b)(iii) The impact of the disease on animal welfare
Parameter 1 – Severity of clinical signs at case level and related level and duration of impairment
S. arizonae
Clinically affected poults may show some or all signs like depression, weakness, anorexia and
diarrhoea. Nervous signs including paralysis, twisted necks and convulsions may occur, and some
individuals develop eye infection resulting in blindness (Shivaprasad et al., 2006; Shivaprasad, 2008;
Hafez, 2013). Poor and uneven growth of survivors may be seen.
S. Gallinarum
Clinical signs of FT are typical of a septicaemic condition in poultry and include increased mortality
and poor quality in chicks hatched from infected eggs. Weakness, decreased appetite, poor growth,
diarrhoea or adherence of faeces to the vent and respiratory signs (gasping) are also seen in those
birds that do not succumb to rapid death (Shivaprasad and Barrow, 2008; Shivaprasad et al., 2013).
Older birds may show signs of anaemia, depression, laboured breathing and diarrhoea causing
adherence of faeces to the vent (OIE, 2017). Survivors may show reduced egg production, egg
hatchability and fertility (Shivaprasad and Barrow, 2008).
In turkeys, internal egg infection leads to death in shell or a moribund state in chicks with rapid
death. Poults showing signs from around day ﬁve may show laboured breathing, greenish diarrhoea,
increased thirst, anorexia, somnolence and retarded growth (Hafez, 2013). In older birds, disease
severity will vary but may include decreased feed consumption, rufﬂed feathers, diarrhoea and
decreases in egg production, fertility and hatchability (Cobb et al., 2005; Shivaprasad and Barrow,
2008). Mortality may occur without other obvious signs, and over short (days) or long (months)
timescales (Cobb et al., 2005; Parmar and Davies, 2007; Ivanics et al., 2008).
S. Pullorum
Clinical signs of Pullorum disease are typical of a septicaemic condition in poultry and include
increased mortality and poor quality in chicks and poults hatched from infected eggs. Weakness,
decreased appetite, poor growth, diarrhoea or adherence of faeces to the vent and respiratory signs
(gasping) are also seen in those birds that do not succumb to rapid death. White diarrhoea may be
seen in turkey poults. Some chicks and poults may become blind and/or show swelling of major limb
joints (Hafez, 2013). Older birds typically are asymptomatic, but may show anorexia, depression,
diarrhoea and dehydration. Survivors and asymptomatic birds may show reduced egg production, egg
hatchability and fertility (Shivaprasad and Barrow, 2008; Hafez, 2013).
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3.1.2.4. Article 7(b)(iv) The impact of the disease on biodiversity and the environment
Biodiversity
Parameter 1 – Endangered wild species affected: listed species as in CITES and/or IUCN list
S. arizonae
The relevant serovars are not considered to pose a signiﬁcant disease threat other than among
domestic turkeys.
S. Gallinarum/S. Pullorum
The pathogen is not considered to pose a signiﬁcant disease threat outside domestic poultry.
Parameter 2 – Mortality in wild species
S. arizonae
Mortality for the relevant serovars other than among domestic turkeys appears to be low.
S. Gallinarum/S. Pullorum
Mortality outside domestic poultry (including pheasants) appears to be low.
Environment
Parameter 3 – Capacity of the pathogen to persist in the environment and cause mortality in wildlife
S. arizonae
Whilst avian wildlife may potentially carry the pathogen, and could theoretically acquire it from
farmed ﬂocks and their environs, there is no evidence of a capacity to cause substantial mortality in
wildlife.
S. Gallinarum
While avian wildlife may carry the pathogen, and potentially acquire it from farmed ﬂocks and their
environs, there is no evidence of a capacity to cause anything other than occasional, sporadic disease
in individuals or groups of free-ranging birds. Predisposing causes for disease in wildlife are not
understood.
S. Pullorum
While avian wildlife may carry the pathogen, and potentially acquire it from farmed ﬂocks and their
environs, there is no evidence of a capacity to cause anything other than occasional, sporadic disease
in individuals or groups of free-ranging birds. Predisposing causes for disease in wildlife are not
understood, but close conﬁnement of commercially reared game birds destined for release into the
wild appears to be contributory in some cases.
3.1.3. Article 7(c) Its potential to generate a crisis situation and its potential use
in bioterrorism
Parameter 1 – Listed in OIE/CFSPH classiﬁcation of pathogens
S. arizonae
CFSPH: S. arizonae is listed among reptile-associated and non-typhoidal Salmonellae, but no
reference to (non-zoonotic) turkey-associated serovars.
OIE: Arizonosis is not listed as a notiﬁable disease.
S. Gallinarum
CFSPH: FT is listed as a disease of poultry/non-poultry birds. It is not on the zoonosis list.
OIE: FT is OIE-listed as a notiﬁable disease. Previously on List B (transmissible diseases considered
to be of socioeconomic and/or public health importance within countries and are signiﬁcant in the
international trade of animals and animal products).
S. Pullorum
CFSPH: Pullorum disease is listed as a disease of poultry/non-poultry birds. Not on the zoonosis list.
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OIE: Pullorum disease is OIE-listed as a notiﬁable disease. Previously on List B (transmissible
diseases considered to be of socioeconomic, and/or public health importance within countries and are
signiﬁcant in the international trade of animals and animal products).
Parameter 2 – Listed in the Encyclopaedia of Bioterrorism Defence of Australia Group
S. arizonae/S. Gallinarum/S. Pullorum
Not listed.
Parameter 3 – Included in any other list of potential bio- agro-terrorism agents
S. arizonae/S. Gallinarum/S. Pullorum
None found.
3.1.4. Article 7(d) The feasibility, availability and effectiveness of the following
disease prevention and control measures
3.1.4.1. Article 7(d)(i) Diagnostic tools and capacities
Availability
Parameter 1 – Ofﬁcially/internationally recognised diagnostic tool, OIE certiﬁed
S. arizonae
Sensitive isolation is possible from environmental material and tissues using OIE-approved culture
methods for motile Salmonella, such as ISO 6579:2002/Amd 1:2007 (Annex D) (OIE, 2016b). In view
of the utility of culture detection of this faecally shed agent, serological monitoring and detection
techniques, although described (Jordan et al., 1976; Shivaprasad, 2008), are currently little used.
S. Gallinarum/S. Pullorum
The stained antigen (whole blood, rapid serum) and tube- or microagglutination serological tests
are internationally recognised and OIE certiﬁed (OIE, 2012).
Certain sampling and culture methods are recommended and detailed in the relevant OIE manual
(OIE, 2012).
Effectiveness
Parameter 2 – Se and Sp of diagnostic test
S. arizonae
AS O18 arizonae are shed consistently in colonised adult birds, environmental sampling should
allow sensitive detection, provided sensitive samples (e.g. boot swabs, dust) and a sensitive culture
technique suited for coping with contaminant organisms is used (Carrique-Mas and Davies, 2008).
Dead in shell embryos, hatch debris and dead poults have also been found to be sensitive indicators of
breeding ﬂock infection (Goetz, 1962; Kumar et al., 1974). Speciﬁcity depends on accurate
identiﬁcation of isolates using appropriate colonial, serological and biochemical discriminators
(Carrique-Mas and Davies, 2008). Provided that isolates are carefully identiﬁed, the positive predictive
value (PPV) of ﬂock screening by culture is high, regardless of underlying risk, although the potential
exists for certain diarizonae or other S. enterica subspecies bearing the O18 antigen to be wrongly
identiﬁed as turkey-speciﬁc isolates. The negative predictive value (NPV) of screening breeding ﬂocks
should be very high if sensitive sampling and culture techniques are used, given the occurrence of
obvious clinical disease and/or egg hatchability problems and low underlying risk of ﬂock infection.
The strength of serological responses appear to vary according to stage of life and the age at
which the bird becomes infected, with peaks described at around 1 month of age and, for later-
infected birds, at point of lay (Kumar et al., 1974).
S. Gallinarum/S. Pullorum
There is limited objective data on test performance, but the evidence indicates that serological
results with existing tests should be interpreted at ﬂock (rather than individual) level, and be
complemented with bacteriological sampling of reacting birds. If the test is to be used for detecting
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individual infected birds for culling, it should be repeated at least twice and preferably until the whole
ﬂock has given at least two negative tests (OIE, 2012).
Speciﬁcity. Serological tests should detect reactors to both Gallinarum and Pullorum biovars,
owing to a shared antigenic structure. A lack of speciﬁcity can be attributed to infections with a variety
of bacteria (coliforms, micrococci, streptococci and others), and non-Pullorum/Gallinarum reactors may
range from few birds in a ﬂock to as high as 30–40% (Shivaprasad and Barrow, 2008). Post-mortem
examination of reacting birds, with bacteriological sampling, is necessary to complement and conﬁrm a
serological diagnosis of ﬂock infection. The whole-blood antigen test is not suitable for use in turkeys
or ducks, owing to a lack of speciﬁcity (OIE, 2012). Tube agglutination tests may be used with these
species, but still produce a low proportion of false positives. Tube agglutination tests can also be used
to conﬁrm rapid slide agglutination test results.
The standard rapid serum agglutination (RSA) test, produced with S. Pullorum antigens by a French
national monitoring laboratory, showed a speciﬁcity of 90%, with undiluted serum in ten 10-week-old
speciﬁc-pathogen-free hens (Proux et al., 2002).
Using 10-week-old speciﬁc pathogen-free hens, Proux et al. (2002) demonstrated 99% (107/108
birds) speciﬁcity of the RSA Gallinarum/Pullorum test using neat serum, and 100% speciﬁcity using
serum diluted 1:4. Speciﬁcity of 100% was also seen in another experimental study (Gast, 1997).
S. Gallinarum
Sensitivity. In one study (Proux et al., 2002), a single (atypical) strain of S. Gallinarum was
administered intramuscularly to ten 10-week-old hens, and sera were examined 2 weeks post-
inoculation using a S. Gallinarum-speciﬁc ELISA as a reference test. Sensitivity was 0%. The authors
cautioned that this represents results from just a single strain of S. Gallinarum, but advised that
antigen from both Gallinarum and Pullorum biovars be included in the RSA, before further evaluation.
Based on this study the sensitivity for FT of a standard stained-antigen Pullorum test is in some doubt,
but the study was small and did not show S. Gallinarum colonisation of the hens at one week after
serological sampling. A recent ﬁeld study in an endemically affected country (Bangladesh) showed
birds that were seronegative with a whole blood stained-antigen to commonly be shedding
S. Gallinarum (Rahman et al., 2011), thus emphasising the importance of selecting appropriate
antigens and ensuring the quality of production and testing, including use of suitable control samples.
S. Pullorum
Sensitivity. With S. Pullorum, there is a variation in the ratio of 121, 122 and 123 subtypes of O
antigen; the standard strain contains more 123 than 122, while the reverse is true of the variant form.
Intermediate forms also exist. Therefore, it is necessary to use a polyvalent antigen in
immunodiagnostic tests. In the study by Proux et al. (2002), birds were inoculated intramuscularly
with one of 11 S. Pullorum strains, and a polyvalent rapid serum agglutination test demonstrated a
sensitivity of 100% (108/108) at 2 weeks post-inoculation.
Another experimental trial, using mature hens inoculated orally with one of six ﬁeld strains, yielded
a sensitivity for detection, depending on inoculated strain, of 40–75% (whole blood antigen test) or
62–94% (tube agglutination test) at six weeks post-inoculation (Gast, 1997). Birds that were culture-
positive at post mortem examination were most often seropositive (92–98% of samples).
Feasibility
Parameter 3 – Type of sample matrix to be tested (blood, tissue, etc.)
S. arizonae
Surveillance sampling is readily performed using culture of environmental (boot or drag) swabs,
dust and hatchery waste.
S. Gallinarum/S. Pullorum
The rapid whole blood plate agglutination test is suitable for use in the ﬁeld. Other validated
serological tests are readily performed in the laboratory. For bacteriological culture, tissue samples are
more rewarding than environmental or faeces samples, owing to low or intermittent shedding and
competing organisms and inhibitory substances (OIE, 2012).
Direct enrichment of the sample in selenite broth, rather than the non-selective pre-enrichment that
is used for non-host-adapted serovars is recommended for both SP and SG biovars of SG.
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3.1.4.2. Article 7(d)(ii) Vaccination
Availability
Parameter 1 – Types of vaccines available on the market (live, inactivated, DIVA, etc.)
S. arizonae
Inactivated autogenous vaccines may be prepared using strains from infected ﬂocks. Aluminium salt
or oil adjuvants have proved effective. There is no commercial vaccine available.
S. Gallinarum
The long-established rough mutant of S. Gallinarum (SG9R) (Harbourne, 1955) is the only licensed
live vaccine strain available. It has been used by various companies, but SG9R vaccines are being
superseded by rationally attenuated strains for non-typhoidal Salmonella infections. Furthermore,
recent concerns over reversion to virulence have led to the vaccine being voluntarily withdrawn in
some countries where FT is not endemic. Molecular genetic evidence of virulent SG9R-related strains in
vaccinated ﬂocks in Europe and Korea have been presented (Kwon and Cho, 2011; Van Immerseel
et al., 2013). Inactivated autogenous vaccines may be prepared using strains from infected ﬂocks.
S. Pullorum
Owing to the successful eradication of S. Pullorum from commercial ﬂocks and the lack of a clinical
problem with outbreaks in mature ﬂocks (by contrast with S. Gallinarum/fowl typhoid), there is little
need or incentive for a licensed vaccine for Pullorum disease. The long-established rough mutant of
S. Gallinarum (SG9R) (Harbourne et al., 1963) is the only licensed live vaccine strain likely to be
efﬁcacious against S. Pullorum, although S. Enteritidis vaccines are also likely to provide some cross-
protection. Where SG9R is marketed it is licensed for fowl typhoid, not Pullorum disease. Recent
concerns over reversion to virulence (Kwon and Cho, 2011; Van Immerseel et al., 2013) has led to the
vaccine being voluntarily withdrawn in some countries where S. Gallinarum is not endemic. Inactivated
autogenous vaccines may be prepared using strains from infected ﬂocks, but again there are few
circumstances where their use would be advocated compared with an eradication strategy.
Parameter 2 – Availability / production capacity (per year)
S. arizonae
There is no commercial vaccine available.
S. Gallinarum/S. Pullorum
Vaccines using SG9R have been widely produced by various companies globally for many years, for
control of typhoidal and non-typhoidal Salmonella (serovar Enteritidis) in Gallus gallus. The availability
of such vaccines in Europe is variable, according to national regulatory policies.
Effectiveness
Parameter 3 – Field protection as reduced morbidity (as reduced susceptibility to infection and/or to
disease)
S. arizonae
Reported effects include, variously, reduced shedding and prevention of systemic infection in
breeders, reduction in the proportion of infected eggs laid, and prevention of infection in progeny from
breeders held in a contaminated environment (Shivaprasad, 2008).
S. Gallinarum
Vaccines for Salmonella are not capable of eradicating infection from ﬂocks but can increase the
threshold for infection, reduce the level of shedding of the organism and reduce vertical transmission
in poultry (OIE, 2012). Vaccination with strain SG9R may sometimes precipitate high mortality in
infected birds (Silva et al., 1981). SG9R vaccine was associated with protection against mortality up to
61 weeks of age in the face of repeated experimental challenge in a farm-scale trial with laying hens
(Lee et al., 2007), but has not always been successful in the face of ﬁeld outbreaks of FT. It is likely to
be used preventatively, in regions where the disease is endemic or considered to be a high risk. There
have been concerns about the potential for reversion of some live vaccines to virulence, resulting in
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outbreaks of FT in vaccinated ﬂocks or on holdings where a proportion of birds have been vaccinated
(Kwon and Cho, 2011; Van Immerseel et al., 2013).
S. Pullorum
Vaccines for Salmonella are not capable of eradicating infection from ﬂocks but can increase the
threshold for infection, reduce the level of shedding of the organism and reduce vertical transmission
in poultry (OIE, 2012). There are few studies on vaccine protection of mature birds or of chicks
hatched from S. Pullorum-infected ﬂocks, as vaccination has not been regarded as a useful control
strategy. Recent studies (Akter et al., 2012; Yin et al., 2015) showed that S. Pullorum, given as a
formalin-killed alum-precipitated vaccine or a rationally attenuated live oral vaccine, provided
protection against clinical effects of intramuscular challenge in 14-week-old (inactivated vaccine) or
12-day-old (live vaccine) chickens, but effects on vertical transmission or viability of derived chicks
were not examined.
Parameter 4 – Duration of protection
S. arizonae
Duration of effects has not been documented.
S. Gallinarum
Reduction of mortality was shown for the duration of a 61-week large-scale trial following
administration of a SG9R vaccine to pullets at 6 and/or 18 weeks of age (Lee et al., 2007). In the ﬁeld,
duration of protection is likely to be variable and it is usual to repeat vaccination at least twice yearly.
S. Pullorum
Reduction of mortality from fowl typhoid was shown for the duration of a 61-week large-scale trial
following administration of a SG9R vaccine to pullets at 6 and/or 18 weeks of age (Lee et al., 2007).
In the ﬁeld, duration of protection is likely to be variable and it is recommended to repeat vaccination
at least twice yearly.
Feasibility
Parameter 5 – Way of administration
S. arizonae
Generally, the inactivated vaccines are given by two or more intramuscular injections.
S. Gallinarum/S. Pullorum
Where it is currently marketed, the SG9R vaccine is administered by subcutaneous injection.
Intramuscular and oral administration has also been used (Shivaprasad and Barrow, 2008), although
the latter routes appear to generate less effective protection (Silva et al., 1981).
3.1.4.3. Article 7(d)(iii) Medical treatments
Availability
Parameter 1 – Types of drugs available on the market
S. arizonae
Antibiotics and chemotherapeutic antimicrobial drugs are the only drugs used to treat avian
arizonosis. Those listed for other systemic avian salmonellosis are likely to be at least partially effective
(Shivaprasad and Barrow, 2008). These include sulfonamides, nitrofurans, aminoglycosides,
tetracyclines and chloramphenicol.
S. Gallinarum
Antibiotics and chemotherapeutic antimicrobial drugs are the only drugs used to treat clinical FT.
Drugs and classes of drugs found to be at least partially effective include sulfonamides, nitrofurans,
aminoglycosides, tetracyclines and chloramphenicol (Shivaprasad and Barrow, 2008). However, in most
cases medication fails to contain infection in large ﬂocks.
AHL assessment on Salmonella infection in poultry (S. Pullorum, S. Gallinarum, S. arizonae)
www.efsa.europa.eu/efsajournal 25 EFSA Journal 2017;15(8):4954
S. Pullorum
Antibiotics and chemotherapeutic antimicrobial drugs are the only drugs used to treat clinical
Pullorum disease. Drugs and classes of drugs found to be at least partially effective include
sulfonamides, nitrofurans, aminoglycosides, tetracyclines and chloramphenicol (Shivaprasad and
Barrow, 2008).
Parameter 2 – Availability / production capacity (per year)
S. arizonae/S. Gallinarum/S. Pullorum
All of the licensed drugs/classes are produced in volume. The availability of some (e.g.
chloramphenicol, furazolidone) for veterinary use is restricted by law in some territories, and their use
is not permitted in the EU.
Effectiveness
Parameter 3 – Therapeutic effects on the ﬁeld (effectiveness)
S. arizonae
Antibiotic/antimicrobial chemotherapeutic treatment of carrier adults does not prevent infection of
eggs (Goetz, 1962). No drug or combination has been found capable of eliminating infection from a
treated ﬂock, but antibacterial drugs may reduce morbidity and losses if given to young poults
(Hinshaw and McNeil, 1946; Kumar et al., 1974), dramatically so if given at the hatchery (Shivaprasad,
2008).
S. Gallinarum/S. Pullorum
No drug or combination has been found capable of eliminating infection from a treated ﬂock,
although the listed drugs have sometimes been found to reduce mortality (Shivaprasad and Barrow,
2008). Only colistin and tetracyclines are permitted to be used for FT/Pullorum disease in laying hens
without the need for withholding eggs from sale, and their effectiveness is limited.
Feasibility
Parameter 4 – Way of administration
S. arizonae
Reportedly effective treatments have been given by injection at the hatchery, and in feed on rearing
premises (Hinshaw and McNeil, 1946; Kumar et al., 1974; Pomeroy et al., 1989; Shivaprasad, 2008).
S. Gallinarum/S. Pullorum
Depending on the class of antimicrobial, effective systemic concentrations, as required for a
septicaemic condition, can be achieved by administration in drinking water (e.g. chlortetracycline) or
by injection (e.g. aminoglycosides). For medication of commercial ﬂocks, daily injection is usually not
feasible.
3.1.4.4. Article 7(d)(iv) Biosecurity measures
Availability
Parameter 1 – Available biosecurity measures
S. arizonae
Biosecurity as recommended and often implemented for Salmonella spp. generally include clean
and secure feed transport and storage, exclusion and control of bird, rodent and other wildlife plus
arthropods, water hygiene, visitor and fomite restrictions, perimeter security and proper disposal of
dead birds.
S. Gallinarum/S. Pullorum
Biosecurity as recommended and often implemented for Salmonella spp. and Campylobacter spp.
generally include clean and secure feed transport and storage, exclusion and control of bird, rodent
and other wildlife plus arthropods, water hygiene, visitor and fomite restrictions, perimeter security
and proper disposal of dead birds (Shivaprasad, 2000).
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Effectiveness
Parameter 2 – Effectiveness of biosecurity measures in preventing the pathogen introduction
S. arizonae
Implementation of total conﬁnement, bird- and rodent-proof buildings and feed hygiene, alongside
thorough cleaning and disinfection, was highly successful at preventing infection of primary breeder
ﬂocks (Shivaprasad, 2008). Segregation of birds of uncertain infection status into small groups in
widely separated pens on disinfected and/or previously unused premises allowed elimination of O18
arizonae following intensive monitoring and culling of all birds in affected pens (Jordan et al., 1976).
S. Gallinarum/S. Pullorum
The effectiveness of biosecurity measures is suggested by the sustained absence of FT/Pullorum
disease in commercial ﬂocks despite intermittent identiﬁcation of the agent in small extensively farmed
ﬂocks in the same countries (Shivaprasad and Barrow, 2008; EFSA, 2009). There is little or no
quantitative data on the effectiveness of speciﬁc measures in respect of FT/Pullorum disease
prevention.
Feasibility
Parameter 3 – Feasibility of biosecurity measures
S. arizonae
Implementation of total conﬁnement, bird- and rodent-proof buildings and feed hygiene, alongside
thorough cleaning and disinfection, was highly successful at preventing infection of primary breeder
ﬂocks (Shivaprasad, 2008). Segregation of birds of uncertain infection status into small groups in
widely separated pens on disinfected and/or previously unused premises allowed elimination of O18
arizonae following intensive monitoring and culling of all birds in affected pens (Jordan et al., 1976).
S. Gallinarum/S. Pullorum
The effectiveness of biosecurity measures is suggested by the sustained absence of FT/Pullorum
disease in commercial ﬂocks despite intermittent identiﬁcation of the agent in small extensively farmed
ﬂocks in the same countries (Anderson et al., 2006; AHVLA, 2008; Shivaprasad and Barrow, 2008).
There is little or no quantitative data on the effectiveness of speciﬁc measures in respect of
FT/Pullorum disease prevention.
3.1.4.5. Article 7(d)(v) Restrictions on the movement of animals and products
Availability
Parameter 1 – Available movement restriction measures
S. arizonae/S. Gallinarum/S. Pullorum
National health and monitoring schemes exist within EU MSs, implementing requirements of Council
Directive 2009/158/EC, as updated by Commission Decision 2011/214/EU2 and Commission
Implementing Decision 2011/879/EU3 for, amongst other things, licensing of intra-community trade,
trade between MS’s and certain third countries, and trade between health scheme members. Council
Directive 2009/158/EC, as updated by Commission Decision 2011/214/EU and Commission
Implementing Decision 2011/879/EU requires removal of approval of the establishment and for trading
movement restrictions to be placed on premises where infection with these organisms is identiﬁed or
suspected. If approval has been withdrawn because of an outbreak caused by S. Pullorum,
S. Gallinarum or S. arizonae, this may be restored after negative results have been recorded in two
tests performed with an interval of at least 21 days on the establishment following sanitary slaughter
of the infected ﬂock and after disinfection for which the effectiveness has been veriﬁed by suitable
tests on dried surfaces. An example of a scheme which is operated by the poultry industry in
2 2011/214/EU: Commission Decision of 1 April 2011 amending Annexes II to IV to Council Directive 2009/158/EC on animal
health conditions governing intra-Community trade in, and imports from third countries of, poultry and hatching eggs. OJ L 90,
6.4.2011, p. 27–49.
3 2011/879/EU: Commission Implementing Decision of 21 December 2011 amending Annexes II and IV to Council Directive
2009/158/EC on animal health conditions governing intra-Community trade in, and imports from third countries of, poultry and
hatching eggs. OJ L 343, 23.12.2011, p. 105–116.
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collaboration with the competent authority is the UK has a Poultry Health Scheme (Defra, 2013),
membership of which is suspended in the event of suspected or diagnosed ﬂock infection with relevant
serovars of S. enterica arizonae/S. Gallinarum/S. Pullorum.
Effectiveness
Parameter 2 – Effectiveness of restriction of animal movement in preventing the between farm spread
S. arizonae/S. Gallinarum/S. Pullorum
The agent has the potential for extended carriage by some birds, can survive on fomites and in
faeces for some time, but is not known to be capable of airborne travel between premises except
perhaps via avian intermediaries. Therefore, restricting the movement of birds from affected ﬂocks will
effectively restrict spread of the agent between premises. However, the agent may additionally be
transferred between premises via eggs, humans (catching crews, shared workers, etc.), vehicles and
other mobile equipment.
S. Gallinarum
Use of second-hand cages and non-national maintenance engineers is thought to have been
responsible for some infections in large laying hen ﬂocks.
Feasibility
Parameter 3 – Feasibility of restriction of animal movement
S. arizonae/S. Gallinarum/S. Pullorum
The principal affected species are usually moved, as whole ﬂocks or substantial proportions thereof,
two or three times in their lives from hatchery to rearing/fattening accommodation, from rearing to
laying or fattening accommodation, and from fattening or laying accommodation to slaughter.
Movement of individual birds or small groups is generally not undertaken in commercial poultry
production. Given the organised, large-scale and relatively infrequent movement of individual
commercial ﬂocks, movement restriction may readily be applied at a ﬂock or premises level if disease is
diagnosed in the ﬂock. Tracing and destruction of eggs from affected breeding ﬂocks should not pose
a major challenge provided batches are routinely tracked appropriately.
S. Gallinarum/S. Pullorum
Restricting the movement of fancy fowl for shows, etc., is potentially more difﬁcult, given the
frequency with which they may be moved, and the comparative lack of statutory regulation on trade
and movement of small numbers of birds within the EU, compared with commercial birds.
3.1.4.6. Article 7(d)(vi) Killing of animals
Availability
Parameter 1 – Available methods for killing animal
S. arizonae/S. Gallinarum/S. Pullorum
Recognised methods of mass killing on-farm include hypercapnia (carbon dioxide exposure), anoxia
(nitrogen or argon in foam, water foam) and ventilation shutdown. Methods used for smaller numbers
of birds include CO2 or gaseous anoxia in containers or conﬁned airtight spaces, injection of chemical
agents (e.g. pentobarbitone), cervical dislocation, percussive stunning, decapitation and electrocution
using appropriately designed equipment (NAHEMS, 2015; OIE, 2016a). However, in the EU according
to the Council Regulation (EC) No 1099/20094, there is a welfare requirement for stunning before (or
as part of) the lethal technique and consequently certain techniques are not permitted. These include
foam smothering without anoxic gas, ventilation shutdown and decapitation, plus electrocution without
a prestun and cervical dislocation outside of limits on weight and number of birds per operator. In
individual cases where, under exceptional circumstances, compliance with those rules may put human
health at risk or may signiﬁcantly slow down the process of eradication of a disease the MS Competent
Authority may derogate from such provisions, but this is unlikely to be the case with
4 Council Regulation (EC) No 1099/2009 of 24 September 2009 on the protection of animals at the time of killing. OJ L 303,
18.11.2009, p. 1–30.
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S. arizonae/S. Gallinarum/S. Pullorum infections. Birds that are not showing symptoms may also be sent
to slaughter plants, with carcasses being used for heat-treated food products or as animal by-products.
Parameter 2 – Effectiveness of killing animals (at farm level or within the farm) for reducing /stopping
spread of the disease
S. arizonae
The greatest beneﬁt of depopulation in respect of preventing spread of disease is likely to occur
when the ﬂock in question is a breeding ﬂock. Methods that do not involve mass-handling of animals
will minimise the risk of disease spread by operators. Given the mode of transmission, killing of a
fattening ﬂock that experienced disease among poults is unlikely to affect control of the disease more
widely.
S. Gallinarum/S. Pullorum
The greatest beneﬁt of depopulation in respect of preventing spread of disease is likely to occur
when the ﬂock in question is a breeding ﬂock. Methods that do not involve mass-handling of animals
will minimise the risk of disease spread by operators. Killing of commercial production ﬂocks will
eliminate the risk of contamination of any equipment, vehicles and personnel that are shared between
premises, provided suitable decontamination of people and equipment used in the depopulation is
performed. Killing of ﬂocks destined for other (laying or fattening) premises will prevent contamination
of those premises. Killing and removal of an infected ﬂock will not prevent carry-over to another ﬂock
on the same premises unless thorough decontamination, including acaricidal treatment if red mite is
present (for S. Gallinarum), is performed between ﬂocks (Parmar and Davies, 2007). Disruption caused
by removing one ﬂock on a multiﬂock site may lead to spread of disease within the holding.
S. Pullorum
Historically, SP was eradicated from many commercial breeding poultry ﬂocks by repeat serological
testing and culling reactors. The limited environmental persistence and infectivity of the organism and
minimal involvement of vectors made this possible, but it would not be economically feasible on
modern large scale breeding enterprises, which are maintained free of infection in most high-income
countries by a high level of biosecurity within the whole breeding pyramid.
Feasibility
Parameter 3 – Feasibility of killing animals
S. arizonae/S. Gallinarum/S. Pullorum
The mass-killing methods detailed previously all have limitations, for example the need for birds to
be at low level with house-wide CO2 killing, the need for suitable foam generation supplies and
equipment for large-scale nitrogen and argon use, and welfare and legal prohibitions on several
techniques, discussed previously. However, many methods are used successfully when needed (and
when selected appropriately) with other disease outbreaks, for example avian inﬂuenza.
3.1.4.7. Article 7(d)(vii) Disposal of carcasses and other relevant animal by-products
Availability
Parameter 1 – Available disposal option
S. arizonae/S. Gallinarum/S. Pullorum
Incineration, slaughter for human consumption (for healthy birds in the ﬂock) or rendering. Other
methods (burial, composting) are not permitted in the EU.
Effectiveness
Parameter 2 – Effectiveness of disposal option
S. arizonae/S. Pullorum
All methods are well-established and may be used successfully (CAST, 2008). Preventing spread of
the infectious agent depends upon excluding access to carcasses by wildlife likely to carry and spread
S. enterica arizonae/S. Pullorum especially wild birds and rodents.
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S. Gallinarum
All methods are well-established and may be used successfully (CAST, 2008). Preventing spread of
the infectious agent depends upon excluding access to carcasses by wildlife likely to carry and spread
S. Gallinarum, i.e. wild birds and rodents. Elimination of red mites by prolonged heat treatment of
poultry houses, as well as effective disinfection, is required to prevent carry-over of infection into
replacement ﬂocks.
Feasibility
Parameter 3 – Feasibility of disposal option
S. arizonae/S. Gallinarum/S. Pullorum
The use of incineration would depend on there being an accessible, suitably licensed incinerator of
suitable capacity. This is unlikely to be universally available.
3.1.5. Article 7(e) The impact of disease prevention and control measures
3.1.5.1. Article 7(e)(i) The direct and indirect costs for the affected sectors and the
economy as a whole
Parameter 1 – Cost of control (e.g. treatment/vaccine, biosecurity)
S. arizonae
In the EU, elimination and exclusion of the disease is the principal control strategy. Therefore costs
of control are essentially those of eradication (as below). Maximal biosecurity is required for the
breeding ﬂocks, which is recommended in any event for disease (including Salmonella) prevention
more generally. Therefore, it is difﬁcult to assign a nominal cost of such measures speciﬁcally for the
prevention and control of S. enterica arizonae.
S. Gallinarum/S. Pullorum
In the EU, elimination and exclusion of the disease is the principal control strategy. Therefore, costs
of control are essentially those of eradication (as below). The same biosecurity and hygiene measures
are used for the prevention and control of non-typhoidal Salmonella, S. Gallinarum/Pullorum and,
where applicable, Campylobacter spp. Therefore, it is difﬁcult to assign a nominal cost of such
measures speciﬁcally for the prevention and control of FT/Pullorum disease.
S. Gallinarum
Current vaccination programmes are subject to the labour cost of injecting birds individually, with
protocols recommending two doses, either of an SG9R live strain or a killed bacterin, or a sequential
combination of both (Paiva et al., 2009).
Parameter 2 – Cost of eradication (culling, compensation)
S. arizonae
Costs depend on the level in the breeding pyramid in which the disease occurs. In the UK, costs of
testing and culling are borne by the ﬂock owner. Insurance policies may be available. Historically,
control was achieved in the USA following ﬁrst recognition of the disease (in the 1940s) by intensive
monitoring of breeder ﬂocks and candidate breeding birds, via serological testing and bacteriological
sampling of poult mortalities, seropositive birds and dead-in-shell embryos (Goetz, 1962). An outbreak
in the UK in 1968 arising from imported eggs was arrested without a complete cull of the affected
ﬂock by serological screening, segregation of birds into small groups on clean premises and further
intensive serological and bacteriological monitoring, with culling of affected groups (Jordan et al.,
1976). Such an approach is likely to be economically feasible only among birds with high genetic value.
S. Gallinarum
Costs depend on the level in the breeding pyramid in which the disease occurs. Test and remove
strategies are not usually employed in the EU, given the high mortality with FT. For such an approach,
the costs of repeated blood sampling and testing all birds (compared with surveillance sampling) may
exceed the value of the ﬂock. In the UK, costs of testing and culling for FT are borne by the ﬂock
owner. Insurance policies may be available, albeit at often prohibitive premium costs.
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S. Pullorum
Costs depend on the level in the breeding pyramid in which the disease occurs. For a test-remove-
retest approach, the costs of repeated blood sampling and testing all birds (compared with surveillance
sampling) may exceed the value of the ﬂock. In the UK, costs of testing and culling for Pullorum
disease are borne by the ﬂock owner. Insurance policies may be available, albeit at often prohibitive
premium costs.
Parameter 3 – Cost of surveillance and monitoring
S. arizonae
This is the predominant cost of S. enterica arizonae in the EU, where the disease has been
eliminated from commercial ﬂocks. Under the UK National Control Programme for Salmonella in turkeys
(Defra, 2008), bacteriological samples (boot swabs +/ dust samples) are to be taken from every
fattening ﬂock, and every three weeks from all breeding ﬂocks, for submission to an approved testing
laboratory. Three-weekly samples of hatchery waste are an alternative for breeding ﬂocks in lay. As an
example, current UK Animal and Plant Health Agency costs (excluding Value Added Tax) are £19.80 for
combined culture of up to 10 swabs.
S. Gallinarum/S. Pullorum
This is the predominant cost of SG/SP in developed countries where the disease has been
eliminated from commercial ﬂocks (Shivaprasad, 2000). As an example, under the UK Poultry Health
Scheme (Defra, 2013), all ﬂocks (fowl, turkeys, ducks, guinea fowl, partridges, pheasant, quails) in lay
(i.e. breeding and commercial egg production) are to be tested at least once a year, with the initial
test at or near the point of lay. Samples either for serology (up to 60 samples, depending on ﬂock
size) or bacteriology (dead-in-shell and cull chicks, meconium or hatch tray liners) are submitted to an
approved testing laboratory. Current UK Animal and Plant Health Agency costs (excluding Value Added
Tax) are between £7.90 and £13.50 per sample for serology and £41.55 for combined culture of up to
60 chick carcasses.
Parameter 4 – Trade loss (bans, embargoes, sanctions) by animal product
S. arizonae
EU rules (Council Directive 2009/158/EC) state that source premises for international trade in
hatching eggs and birds should be regularly monitored to demonstrate freedom from S. enterica
arizonae. However, country-wide freedom from the disease is not required. Given the low zoonosis
risk, trade in eggs and poultry for human consumption is not subject to controls relating to the
presence or absence of S. enterica arizonae in source ﬂocks.
S. Gallinarum
EU rules (Council Directive 2009/158/EC) and OIE recommendations (OIE, 2017) state that source
ﬂocks for international trade in hatching eggs and birds should be certiﬁed as free from FT. However,
country-wide freedom from the disease is not required. Given the negligible zoonosis risk, trade in
eggs and poultry for human consumption is not subject to controls relating to the presence or absence
of FT in source ﬂocks.
S. Pullorum
EU rules (Council Directive 2009/158/EC) and OIE recommendations (OIE, 2017) state that source
ﬂocks for international trade in hatching eggs and birds should be certiﬁed as free from Pullorum
disease. However, country-wide freedom from the disease is not required. Given the low zoonosis risk,
trade in eggs and poultry for human consumption is not subject to controls relating to the presence or
absence of S. Pullorum in source ﬂocks.
Parameter 5 – Importance of the disease for the affected sector (% loss or € lost compared to
business amount of the sector)
S. arizonae
Currently, the costs of the disease within the EU are mostly those of surveillance. In the event of a
substantial outbreak, for example occurring following undetected infection in a breeding ﬂock, the
short-term cost of detection, culling, decontamination and repopulation could be substantial.
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S. Gallinarum/S. Pullorum
Currently, the costs of the disease within the EU are mostly those of surveillance. In the event of a
substantial outbreak, for example occurring following undetected infection in a breeding ﬂock, the
short-term cost of detection, culling, decontamination and repopulation could be substantial. Such a
scenario unfolded in the USA in the early 1990s with the S. Pullorum biovar (Shivaprasad and Barrow,
2008), although a quantitative assessment of the costs was not reported. In 1939, before the biovars
Gallinarum and Pullorum were eradicated from the poultry industry in the USA, an estimate was given
that Pullorum disease cost that industry ‘hundreds of thousands of dollars’ per year (Bullis, 1977).
3.1.5.2. Article 7(e)(ii) The societal acceptance of disease prevention and control
measures
S. arizonae/S. Gallinarum/S. Pullorum
There is broad public acquiescence in the culling of poultry for disease control purposes. Concern
has been expressed by campaigning groups about the necessity for culling (Laville and Harding, 2005)
or methods used, particularly ventilation shutdown in recent avian inﬂuenza outbreaks (CWF, 2016),
but objections outside of groups opposed to intensive farming appear to be minimal.
3.1.5.3. Article 7(e)(iii) The welfare of affected subpopulations of kept and wild animals
Parameter 1 – Welfare impact of control measures on domestic animals
S. arizonae
Culling interventions in breeding ﬂocks are subject to welfare considerations around handling for
blood sampling, transport and killing. These are not peculiar to S. enterica arizonae control.
S. Gallinarum/S. Pullorum
Culling or test and remove interventions in commercial ﬂocks are subject to welfare considerations
around handling for blood sampling, transport and killing. These are not peculiar to S. Gallinarum/
S. Pullorum control. Occasional disease in pet chickens, fancy fowl and small backyard ﬂocks may be
treated, if desired by the owner, with euthanasia of any moribund birds. However, culling of affected
birds or the whole ﬂock is likely to be recommended, using small-scale euthanasia methods such as
lethal injection or cervical dislocation. Given the nature of the human–chicken relationship, many
owners accept death and culling of clinical cases without veterinary involvement, although breeding
and showing enthusiasts who own rare breeds may need more persuading, on welfare and disease
control grounds, to euthanise birds.
Parameter 2 – Wildlife depopulation as control measure
S. arizonae
While close control of wildlife access to breeding ﬂocks is highly important in the prevention of
infection, depopulation of wild birds or other animals has not been used as a control measure. Pest
control biosecurity measures around poultry establishments include exclusion (not usually killing) of
wild birds, and rodent baiting, trapping and exclusion using conventionally accepted and licensed
methods, albeit with some welfare compromises for the controlled species.
S. Gallinarum/S. Pullorum
Depopulation of wild birds has not been used as a control measure, given the sporadic carriage and
rare occurrence of disease associated with S. Gallinarum in wild species, and the well-established
effectiveness of other controls on the transmission of S. Gallinarum within and between commercial
ﬂocks. Pest control biosecurity measures around poultry establishments include exclusion (not usually
killing) of wild birds, and rodent baiting, trapping and exclusion using conventionally accepted and
licensed methods, albeit with some welfare compromises for the controlled species.
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3.1.5.4. Article 7(e)(iv) The environment and biodiversity
Environment
Parameter 1 – Use and potential residuals of biocides or medical drugs in environmental compartments
(soil, water, feed, manure)
S. arizonae
In developed countries, antimicrobial drugs are rarely used in commercial-sized ﬂocks affected by
S. enterica arizonae. Biocides are used for routinely for cleaning and disinfection between ﬂocks
(McLaren et al., 2011), and not speciﬁcally for control and prevention of arizonosis. Therefore, the use
and amount of such chemical agents cannot be ascribed speciﬁcally to S. enterica arizonae control.
Agents used include environmentally short-lived biocides such as peroxygen compounds, halogens and
aldehydes, or more persistent chemicals such as quaternary ammonium and phenolic compounds.
Concerns regarding biocide and antimicrobial resistance as a consequence of the use of disinfectants
on farms are not currently supported by available data (Wales and Davies, 2015).
S. Gallinarum
In developed countries, antimicrobial drugs are rarely used in commercial-sized ﬂocks affected by
FT. Biocides are used for routinely for cleaning and disinfection between ﬂocks (McLaren et al., 2011),
and not speciﬁcally for control and prevention of FT. Therefore, the use and amount of such chemical
agents cannot be ascribed speciﬁcally to FT control, other than occasionally in response to an
outbreak. Agents used include environmentally short-lived biocides such as peroxygen compounds,
halogens and aldehydes, or more persistent chemicals such as quaternary ammonium and phenolic
compounds. Concerns regarding biocide and antimicrobial resistance as a consequence of the use of
disinfectants on farms are not currently supported by available data (Wales and Davies, 2015).
Large volumes of diesel oil are needed to heat poultry farms for a sufﬁcient period to eliminate red
mite carriers of S. Gallinarum. Persistent acaricides are also likely to be used.
S. pullorum
In developed countries, antimicrobial drugs are rarely used in commercial-sized ﬂocks affected by
Pullorum disease. Biocides are used for routinely for cleaning and disinfection between ﬂocks (McLaren
et al., 2011), and not speciﬁcally for control and prevention of Pullorum disease. Therefore, the use
and amount of such chemical agents cannot be ascribed speciﬁcally to Pullorum disease control, other
than occasionally in response to an outbreak. Agents used include environmentally short-lived biocides
such as peroxygen compounds, halogens and aldehydes, or more persistent chemicals such as
quaternary ammonium and phenolic compounds. Concerns regarding biocide and antimicrobial
resistance as a consequence of the use of disinfectants on farms are not currently supported by
available data (Wales and Davies, 2015).
Biodiversity
Parameter 2 – Mortality in wild species
S. arizonae
S. enterica arizonae of turkey-related serovars does not appear to be associated with substantial
wild species mortality.
S. Gallinarum/S. Pullorum
Being highly host-adapted, S. Gallinarum/S. Pullorum appears to cause only sporadic disease or
occasional outbreaks in wild birds, with a very restricted number of species within which this has been
reported (Shivaprasad and Barrow, 2008). Therefore, wild species mortality appears to be very low.
3.2. Assessment according to Article 5 criteria
This section presents the results of the expert judgement on the criteria of Article 5 of the AHL
about Salmonella infection in poultry with serotypes of animal health relevance (S. Pullorum,
S. Gallinarum and S. arizonae) (Table 3). The expert judgement was based on Individual and
Collective Behavioural Aggregation (ICBA) approach described in detail in the opinion on the
methodology (EFSA AHAW Panel, 2017). Experts have been provided with information of the disease
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factsheet mapped into Article 5 criteria (see supporting information, Annex A), based on that the
experts indicate their Y/N or ‘na’ judgement on each criterion of Article 5, and the reasoning
supporting their judgement.
The minimum number of judges in the judgement was 11. The expert judgement was conducted
as described in the methodological opinion (EFSA AHAW Panel, 2017). For details on the interpretation
of the questions, see Appendix B of the methodological opinion (EFSA AHAW Panel, 2017).
3.2.1. Outcome of the assessment of Salmonella infection in poultry with
serotypes of animal health relevance (S. Pullorum, S. Gallinarum and
S. arizonae) according to criteria of Article 5(3) of the AHL on its eligibility
to be listed
As from the legal text of the AHL, a disease is considered eligible to be listed as laid down in Article
5 if it fulﬁls all criteria of the ﬁrst set from A(i) to A(v) and at least one of the second set of criteria
from B(i) to B(v). According to the assessment methodology (EFSA AHAW Panel, 2017), a criterion is
considered fulﬁlled when the outcome is ‘Yes’. According to the results shown in Table 3, Salmonella
complies with all criteria of the ﬁrst set and with two of the second set. Therefore, Salmonella can be
considered eligible to be listed for Union intervention as laid down in Article 5(3) of the AHL.
3.3. Assessment according to Article 9 criteria
This section presents the results of the expert judgement on the criteria of Annex IV referring to
categories as in Article 9 of the AHL about Salmonella infection in poultry with serotypes of animal
health relevance (S. Pullorum, S. Gallinarum and S. arizonae) (Tables 4–8). The expert judgement was
based on ICBA approach described in detail in the opinion on the methodology. Experts have been
provided with information of the disease factsheet mapped into Article 9 criteria (see supporting
information, Annex A), based on that the experts indicate their Y/N or ‘na’ judgement on each criterion
of Article 9, and the reasoning supporting their judgement. The experts decided to assess some Article
9 criteria separately for the Salmonella pathogens, on the basis of the evidence available. In this case
Table 3: Outcome of the expert judgement on the Article 5 criteria for Salmonella infection in
poultry with serotypes of animal health relevance (S. Pullorum, S. Gallinarum and
S. arizonae)
Criteria to be met by the disease:
According to AHL, a disease shall be included in the list referred to in point (b) of paragraph 1 of
Article 5 if it has been assessed in accordance with Article 7 and meets all of the following criteria
Final
outcome
A(i) The disease is transmissible Y
A(ii) Animal species are either susceptible to the disease or vectors and reservoirs thereof exist in
the Union
Y
A(iii) The disease causes negative effects on animal health or poses a risk to public health due to
its zoonotic character
Y
A(iv) Diagnostic tools are available for the disease Y
A(v) Risk-mitigating measures and, where relevant, surveillance of the disease are effective and
proportionate to the risks posed by the disease in the Union
Y
At least one criterion to be met by the disease:
In addition to the criteria set out above at points A(i)-A(v), the disease needs to fulﬁl at least one of the
following criteria
B(i) The disease causes or could cause signiﬁcant negative effects in the Union on animal health,
or poses or could pose a signiﬁcant risk to public health due to its zoonotic character
Y
B(ii) The disease agent has developed resistance to treatments and poses a signiﬁcant danger to
public and/or animal health in the Union
N
B(iii) The disease causes or could cause a signiﬁcant negative economic impact affecting
agriculture or aquaculture production in the Union
Y
B(iv) The disease has the potential to generate a crisis or the disease agent could be used for the
purpose of bioterrorism
N
B(v) The disease has or could have a signiﬁcant negative impact on the environment, including
biodiversity, of the Union
N
Colour code: green = consensus (Yes/No).
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in Tables 4–6, the outcome of the assessment is reported by pathogen. The minimum number of
judges in the judgement was 10. The expert judgement was conducted as described in the
methodological opinion (EFSA AHAW Panel, 2017). For details on the interpretation of the questions,
see Appendix B of the methodological opinion (EFSA AHAW Panel, 2017).
Table 4: Outcome of the expert judgement related to the criteria of Section 1 of Annex IV
(category A of Article 9) for Salmonella infection in poultry with serotypes of animal health
relevance (S. Pullorum, S. Gallinarum and S. arizonae) (CI = current impact; PI = potential
impact)
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final outcome
S.
Pullorum
S.
Gallinarum
S.
arizonae
1 The disease is not present in the territory of the Union OR present
only in exceptional cases (irregular introductions) OR present in
only in a very limited part of the territory of the Union
NC NC NC
2.1 The disease is highly transmissible NC NC na
2.2 There be possibilities of airborne or waterborne or vector-borne
spread
Y na
2.3 The disease affects multiple species of kept and wild animals OR
single species of kept animals of economic importance
Y
2.4 The disease may result in high morbidity and signiﬁcant mortality
rates
Y
At least one criterion to be met by the disease:
In addition to the criteria set out above at points 1–2.4, the disease needs to fulﬁl at least one of the following criteria
3 The disease has a zoonotic potential with signiﬁcant consequences
on public health, including epidemic or pandemic potential OR
possible signiﬁcant threats to food safety
N
4 (CI) The disease has a signiﬁcant impact on the economy of the
Union, causing substantial costs, mainly related to its direct
impact on the health and productivity of animals
N
4 (PI) The disease has a signiﬁcant impact on the economy of the
Union, causing substantial costs, mainly related to its direct
impact on the health and productivity of animals
Y
5(a)(CI) The disease has a signiﬁcant impact on society, with in particular
an impact on labour markets
N
5(a)(PI) The disease has a signiﬁcant impact on society, with in particular
an impact on labour markets
N
5(b)(CI) The disease has a signiﬁcant impact on animal welfare, by
causing suffering of large numbers of animals
N
5(b)(PI) The disease has a signiﬁcant impact on animal welfare, by
causing suffering of large numbers of animals
Y
5(c)(CI) The disease has a signiﬁcant impact on the environment, due to
the direct impact of the disease OR due to the measures taken
to control it
N
5(c)(PI) The disease has a signiﬁcant impact on the environment, due to
the direct impact of the disease OR due to the measures taken
to control it
N
5(d)(CI) The disease has a signiﬁcant impact on a long-term effect on
biodiversity or the protection of endangered species or breeds,
including the possible disappearance or long-term damage to
those species or breeds
N
5(d)(PI) The disease has a signiﬁcant impact on a long-term effect on
biodiversity or the protection of endangered species or breeds,
including the possible disappearance or long-term damage to
those species or breeds
N
Colour code: green = consensus (Yes/No); yellow = no consensus (NC); red = not applicable (na), i.e. insufﬁcient evidence or
not relevant to judge.
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Table 5: Outcome of the expert judgement related to the criteria of Section 2 of Annex IV
(category B of Article 9) for Salmonella infection in poultry with serotypes of animal health
relevance (S. Pullorum, S. Gallinarum and S. arizonae) (CI = current impact; PI = potential
impact)
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final outcome
S.
Pullorum
S.
Gallinarum
S.
arizonae
1 The disease is present in the whole OR part of the Union territory
with an endemic character AND (at the same time) several
Member States or zones of the Union are free of the disease
NC NC NC
2.1 The disease is moderately to highly transmissible NC NC na
2.2 There be possibilities of airborne or waterborne or vector-borne
spread
Y na
2.3 The disease affects single or multiple species Y
2.4 The disease may result in high morbidity with in general low
mortality
N
At least one criterion to be met by the disease:
In addition to the criteria set out above at points 1–2.4, the disease needs to fulﬁl at least one of the following
criteria
3 The disease has a zoonotic potential with signiﬁcant
consequences on public health, including epidemic potential OR
possible signiﬁcant threats to food safety
N
4 (CI) The disease has a signiﬁcant impact on the economy of the
Union, causing substantial costs, mainly related to its direct
impact on the health and productivity of animals
N
4 (PI) The disease has a signiﬁcant impact on the economy of the
Union, causing substantial costs, mainly related to its direct
impact on the health and productivity of animals
Y
5(a)(CI) The disease has a signiﬁcant impact on society, with in particular
an impact on labour markets
N
5(a)(PI) The disease has a signiﬁcant impact on society, with in particular
an impact on labour markets
N
5(b)(CI) The disease has a signiﬁcant impact on animal welfare, by
causing suffering of large numbers of animals
N
5(b)(PI) The disease has a signiﬁcant impact on animal welfare, by
causing suffering of large numbers of animals
Y
5(c)(CI) The disease has a signiﬁcant impact on the environment, due to
the direct impact of the disease OR due to the measures taken
to control it
N
5(c)(PI) The disease has a signiﬁcant impact on the environment, due to
the direct impact of the disease OR due to the measures taken
to control it
N
5(d)(CI) The disease has a signiﬁcant impact on a long-term effect on
biodiversity or the protection of endangered species or breeds,
including the possible disappearance or long-term damage to
those species or breeds
N
5(d)(PI) The disease has a signiﬁcant impact on a long-term effect on
biodiversity or the protection of endangered species or breeds,
including the possible disappearance or long-term damage to
those species or breeds
N
Colour code: green = consensus (Yes/No); yellow = no consensus (NC); red = not applicable (na), i.e. insufﬁcient evidence or
not relevant to judge.
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Table 6: Outcome of the expert judgement related to the criteria of Section 3 of Annex IV
(category C of Article 9) for Salmonella infection in poultry with serotypes of animal health
relevance (S. Pullorum, S. Gallinarum and S. arizonae) (CI = current impact; PI = potential
impact)
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final outcome
S.
Pullorum
S.
Gallinarum
S.
arizonae
1 The disease is present in the whole OR part of the Union
territory with an endemic character
NC NC NC
2.1 The disease is moderately to highly transmissible NC NC na
2.2 The disease is transmitted mainly by direct or indirect
transmission
Y
2.3 The disease affects single or multiple species Y
2.4 The disease usually does not result in high morbidity and has
negligible or no mortality AND often the most observed effect
of the disease is production loss
N
At least one criterion to be met by the disease:
In addition to the criteria set out above at points 1–2.4, the disease needs to fulﬁl at least one of the following
criteria
3 The disease has a zoonotic potential with signiﬁcant
consequences on public health, or possible signiﬁcant threats
to food safety
N
4(CI) The disease has a signiﬁcant impact on the economy of parts
of the Union, mainly related to its direct impact on certain
types of animal production systems
N
4(PI) The disease has a signiﬁcant impact on the economy of parts
of the Union, mainly related to its direct impact on certain
types of animal production systems
N
5(a)(CI) The disease has a signiﬁcant impact on society, with in
particular an impact on labour markets
N
5(a)(PI) The disease has a signiﬁcant impact on society, with in
particular an impact on labour markets
N
5(b)(CI) The disease has a signiﬁcant impact on animal welfare, by
causing suffering of large numbers of animals
N
5(b)(PI) The disease has a signiﬁcant impact on animal welfare, by
causing suffering of large numbers of animals
Y
5(c)(CI) The disease has a signiﬁcant impact on the environment, due
to the direct impact of the disease OR due to the measures
taken to control it
N
5(c)(PI) The disease has a signiﬁcant impact on the environment, due
to the direct impact of the disease OR due to the measures
taken to control it
N
5(d)(CI) The disease has a signiﬁcant impact on a long-term effect on
biodiversity or the protection of endangered species or
breeds, including the possible disappearance or long-term
damage to those species or breeds
N
5(d)(PI) The disease has a signiﬁcant impact on a long-term effect on
biodiversity or the protection of endangered species or
breeds, including the possible disappearance or long-term
damage to those species or breeds
N
Colour code: green = consensus (Yes/No); yellow = no consensus (NC); red = not applicable (na), i.e. insufﬁcient evidence or
not relevant to judge.
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3.3.1. Non-consensus questions
This section displays the assessment related to each criterion of Annex IV referring to the
categories of Article 9 of the AHL where no consensus was achieved in form of tables (Tables 9–13).
The proportion of Y, N or ‘na’ answers are reported, followed by the list of different supporting views
for each answer.
Reasoning supporting the judgement
Supporting Yes for 1 (cat.A):
• Disease due to S. Pullorum infection is reported sporadically in the EU.
• Eleven MS’s reported S. Pullorum infection in the last 10 years, but in the last complete year
for which data are available (2015), there have been no reports of Pullorum disease.
Supporting Yes for 1 (cat.B):
• Disease due to S. Pullorum infection has been reported sporadically in the EU from 12 member
states since 2005.
Table 7: Outcome of the expert judgement related to the criteria of Section 4 of Annex IV
(category D of Article 9) for Salmonella infection in poultry with serotypes of animal health
relevance (S. Pullorum, S. Gallinarum and S. arizonae)
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final
outcome
D The risk posed by the disease in question can be effectively and proportionately mitigated by
measures concerning movements of animals and products in order to prevent or limit its
occurrence and spread
Y
The disease fulﬁls criteria of Sections 1, 2, 3 or 5 of Annex IV of AHL Y
Colour code: green = consensus (Yes/No)
Table 8: Outcome of the expert judgement related to the criteria of Section 5 of Annex IV
(category E of Article 9) for Salmonella infection in poultry with serotypes of animal health
relevance (S. Pullorum, S. Gallinarum and S. arizonae)
Diseases in category E need to fulﬁl criteria of Sections 1, 2 or 3 of Annex IV of AHL and/or
the following:
Final
outcome
E Surveillance of the disease is necessary for reasons relating to animal health, animal welfare,
human health, the economy, society or the environment
(If a disease fulﬁls the criteria as in Article 5, thus being eligible to be listed, consequently
category E would apply.)
Y
Colour code: green = consensus (Yes/No).
Table 9: Outcome of the expert judgement related to criterion 1 of Article 9 for S. Pullorum
Question
Final
outcome
Response
Y
(%)
N
(%)
na
(%)
1(cat.A) The disease is not present in the territory of the Union OR present
only in exceptional cases (irregular introductions) OR present in
only in a very limited part of the territory of the Union
NC 64 36 0
1(cat.B) The disease is present in the whole OR part of the Union territory
with an endemic character AND (at the same time) several
Member States or zones of the Union are free of the disease
NC 18 82 0
1(cat.C) The disease is present in the whole OR part of the Union territory
with an endemic character
NC 18 82 0
NC: non-consensus; number of judges: 11.
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Supporting Yes for 1 (cat.C):
• S. Pullorum infection can be widespread and possibly under-reported, e.g. in exotic animals
and wildlife, with an endemic character.
Reasoning supporting the judgement
Supporting Yes for 1 (cat.A):
• Disease due to S. Gallinarum infection is reported sporadically in the EU.
Supporting Yes for 1 (cat.B):
• Nine MS’s have reported S. Gallinarum in the last 10 years: Belgium, Bulgaria, France,
Germany, Hungary, Italy, the Netherlands, Romania and the UK. In the last complete year
(2015), one MS (Italy) reported disease and another one (Romania) reported infection.
Supporting Yes for 1 (cat.C):
• S. Gallinarum infections can be widespread and possibly under-reported, e.g. in exotic animals
and wildlife, with an endemic character.
Reasoning supporting the judgement
Supporting Yes for 1 (cat.A):
• Disease due to S. arizonae infection is not reported in the EU.
Supporting Yes for 1 (cat.B):
• S. arizonae has not been detected during last years in turkeys however it could be under-
reported and could be detected in wildlife.
Table 11: Outcome of the expert judgement related to criterion 1 of Article 9 for S. arizonae
Question
Final
outcome
Response
Y
(%)
N
(%)
na
(%)
1(cat.A) The disease is not present in the territory of the Union OR present
only in exceptional cases (irregular introductions) OR present in
only in a very limited part of the territory of the Union
NC 63 37 0
1(cat.B) The disease is present in the whole OR part of the Union territory
with an endemic character AND (at the same time) several
Member States or zones of the Union are free of the disease
NC 27 73 0
1(cat.C) The disease is present in the whole OR part of the Union territory
with an endemic character
NC 9 91 0
NC: non-consensus; number of judges: 11.
Table 10: Outcome of the expert judgement related to criterion 1 of Article 9 for S. Gallinarum
Question
Final
outcome
Response
Y
(%)
N
(%)
na
(%)
1(cat.A) The disease is not present in the territory of the Union OR present
only in exceptional cases (irregular introductions) OR present in
only in a very limited part of the territory of the Union
NC 55 45 0
1(cat.B) The disease is present in the whole OR part of the Union territory
with an endemic character AND (at the same time) several
Member States or zones of the Union are free of the disease
NC 27 73 0
1(cat.C) The disease is present in the whole OR part of the Union territory
with an endemic character
NC 18 82 0
NC: non-consensus; number of judges: 11.
AHL assessment on Salmonella infection in poultry (S. Pullorum, S. Gallinarum, S. arizonae)
www.efsa.europa.eu/efsajournal 39 EFSA Journal 2017;15(8):4954
Supporting Yes for 1 (cat.C):
• S. arizonae infections can be widespread and possibly under-reported, e.g. in exotic animals
and wildlife, with an endemic character.
Reasoning supporting the judgement
Supporting Yes for 2.1 (cat.A):
• According to the factsheet, transmission between newly hatched chicks can be rapid enough to
generate and sustain an outbreak with high morbidity and mortality. In general, Salmonella
species are rapidly transmitted, and most individuals become infected within a few days of
being introduced into a na€ıve ﬂock.
Supporting Yes for 2.1 (cat.B,C):
• The transmission rate is highly variable.
Reasoning supporting the judgement
Supporting Yes for 2.1 (cat.A):
• According to the factsheet, transmission between newly hatched chicks can be rapid enough to
generate and sustain an outbreak with high morbidity and mortality.
Supporting Yes for 2.1 (cat.B,C):
• The transmission rate is highly variable.
3.3.2. Outcome of the assessment of criteria in Annex IV for Salmonella
infection in poultry with serotypes of animal health relevance
(S. Pullorum, S. Gallinarum and S. arizonae) for the purpose of
categorisation as in Article 9 of the AHL
As from the legal text of the AHL, a disease is considered ﬁtting in a certain category (A, B, C, D or
E corresponding to point (a) to point (e) of Article 9(1) of the AHL) if it is eligible to be listed for Union
intervention as laid down in Article 5(3) and fulﬁls all criteria of the ﬁrst set from 1 to 2.4 and at least
one of the second set of criteria from 3 to 5(d) as shown in Tables 4–8. According to the assessment
methodology (EFSA AHAW Panel, 2017), a criterion is considered fulﬁlled when the outcome is ‘Yes’.
With respect to different type of impact where the assessment is divided into current and potential
impact, a criterion will be considered fulﬁlled if at least one of the two outcomes is ‘Y’ and, in case of
no ‘Y’, the assessment is inconclusive if at least one outcome is ‘NC’.
A description of the outcome of the assessment of criteria in Annex IV for Salmonella infection in
poultry with serotypes of animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae) for the
purpose of categorisation as in Article 9 of the AHL is presented in Tables 14–16.
Table 12: Outcome of the expert judgement related to criterion 2.1 of Article 9 for S. Pullorum
Question
Final
outcome
Response
Y
(%)
N
(%)
na
(%)
2.1(cat.A) The disease is highly transmissible NC 27 73 0
2.1(cat.B,C) The disease is moderately to highly transmissible NC 73 27 0
NC: non-consensus; number of judges: 11.
Table 13: Outcome of the expert judgement related to criterion 2.1 of Article 9 for S. Gallinarum
Question
Final
outcome
Response
Y
(%)
N
(%)
na
(%)
2.1(cat.A) The disease is highly transmissible NC 27 73 0
2.1(cat.B,C) The disease is moderately to highly transmissible NC 73 27 0
NC: non-consensus; number of judges: 11.
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Table 15: Outcome of the assessment of criteria in Annex IV for S. Gallinarum for the purpose of
categorisation as in Article 9 of the AHL (CI = current impact; PI = potential impact)
Category
Article 9 criteria
1° set of criteria 2° set of criteria
1 2.1 2.2 2.3 2.4 3 4 5a 5b 5c 5d
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A NC NC Y Y Y N CI: N
PI: Y
N CI: N
PI: Y
N N
B NC NC Y Y N N CI: N
PI: Y
N CI: N
PI: Y
N N
C NC NC Y Y N N N N CI: N
PI: Y
N N
D Y
E Y
Table 14: Outcome of the assessment of criteria in Annex IV for S. Pullorum for the purpose of
categorisation as in Article 9 of the AHL (CI = current impact; PI = potential impact)
Category
Article 9 criteria
1° set of criteria 2° set of criteria
1 2.1 2.2 2.3 2.4 3 4 5a 5b 5c 5d
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A NC NC Y Y Y N CI: N
PI: Y
N CI: N
PI: Y
N N
B NC NC Y Y N N CI: N
PI: Y
N CI: N
PI: Y
N N
C NC NC Y Y N N N N CI: N
PI: Y
N N
D Y
E Y
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According to the assessment here performed, Salmonella infection in poultry with serotypes of
animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae) complies with the following
criteria of the Sections 1–5 of Annex IV of the AHL for the application of the disease prevention and
control rules referred to in points (a) to (e) of Article 9(1):
1) To be assigned to category A, a disease needs to comply with all criteria of the ﬁrst set
(1, 2.1–2.4) and according to the assessment S. Pullorum and S. Gallinarum comply with
criteria 2.2, 2.3 and 2.4 and the assessment is inconclusive on compliance with criteria 1 and
2.1, whereas S. arizonae complies with criterion 2.3 and 2.4, the assessment is not
applicable on criteria 2.1 and 2.2 and inconclusive on compliance with criterion 1. To be
eligible for category A, a disease needs to comply additionally with one of the criteria of the
second set (3, 4, 5a–d) and S. Pullorum, S. Gallinarum and S. arizonae comply with criteria 4
and 5b, but not with 3, 5a, 5c and 5d.
2) To be assigned to category B, a disease needs to comply with all criteria of the ﬁrst set
(1, 2.1–2.4) and according to the assessment S. Pullorum and S. Gallinarum comply with
criteria 2.2 and 2.3, but not with criterion 2.4 and the assessment is inconclusive on
compliance with criteria 1 and 2.1. S. arizonae complies with criterion 2.3, but not with
criterion 2.4, the assessment is not applicable on criteria 2.1 and 2.2 and inconclusive on
compliance with criterion 1. To be eligible for category B, a disease needs to comply
additionally with one of the criteria of the second set (3, 4, 5a–d) and S. Pullorum,
S. Gallinarum and S. arizonae comply with criteria 4 and 5b, but not with 3, 5a, 5c and 5d.
3) To be assigned to category C, a disease needs to comply with all criteria of the ﬁrst set
(1, 2.1–2.4) and according to the assessment S. Pullorum and S. Gallinarum comply with
criteria 2.2 and 2.3, but not with criterion 2.4 and the assessment is inconclusive on
compliance with criteria 1 and 2.1. S. arizonae complies with criteria 2.2 and 2.3, but not
with criterion 2.4, the assessment is not applicable on criterion 2.2 and inconclusive on
compliance with criterion 1. To be eligible for category C, a disease needs to comply
additionally with one of the criteria of the second set (3, 4, 5a–d) and S. Pullorum,
S. Gallinarum and S. arizonae comply with criterion 5b, but not with 3, 4, 5a, 5c and 5d.
4) To be assigned to category D, a disease needs to comply with criteria of Section 1, 2, 3 or 5 of
Annex IV of the AHL and with the speciﬁc criterion D of Section 4, with which Salmonella complies.
Table 16: Outcome of the assessment of criteria in Annex IV for S. arizonae for the purpose of
categorisation as in Article 9 of the AHL (CI = current impact; PI = potential impact)
Category
Article 9 criteria
1° set of criteria 2° set of criteria
1 2.1 2.2 2.3 2.4 3 4 5a 5b 5c 5d
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A NC na na Y Y N CI: N
PI: Y
N CI: N
PI: Y
N N
B NC na na Y N N CI: N
PI: Y
N CI: N
PI: Y
N N
C NC na Y Y N N N N CI: N
PI: Y
N N
D Y
E Y
AHL assessment on Salmonella infection in poultry (S. Pullorum, S. Gallinarum, S. arizonae)
www.efsa.europa.eu/efsajournal 42 EFSA Journal 2017;15(8):4954
5) To be assigned to category E, a disease needs to comply with criteria of Section 1, 2 or 3 of
Annex IV of the AHL and/or the surveillance of the disease is necessary for reasons relating to
animal health, animal welfare, human health, the economy, society or the environment. The
latter is applicable if a disease fulﬁls the criteria as in Article 5, with which Salmonella complies.
3.4. Assessment of Article 8
This section presents the results of the assessment on the criteria of Article 8(3) of the AHL about
Salmonella infection in poultry with serotypes of animal health relevance (S. Pullorum, S. Gallinarum
and S. arizonae). The Article 8(3) criteria are about animal species to be listed, as it reads below:
‘3. Animal species or groups of animal species shall be added to this list if they are affected or if
they pose a risk for the spread of a speciﬁc listed disease because:
a) they are susceptible for a speciﬁc listed disease or scientiﬁc evidence indicates that such
susceptibility is likely; or
b) they are vector species or reservoirs for that disease, or scientiﬁc evidence indicates that such
role is likely’.
For this reason, the assessment on Article 8 criteria is based on the evidence as extrapolated from
the relevant criteria of Article 7, i.e. the ones related to susceptible and reservoir species or routes of
transmission, which cover also possible role of biological or mechanical vectors.5 According to the
mapping, as presented in Table 5, Section 3.2 of the scientiﬁc opinion on the ad hoc methodology
(EFSA AHAW Panel, 2017), the main animal species to be listed for Salmonella infection in poultry with
serotypes of animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae) according to the
criteria of Article 8(3) of the AHL are as displayed in Tables 17–19.
Table 17: Main animal species to be listed for Salmonella Pullorum infection in poultry according to
criteria of Article 8 (source: data reported in Section 3.1.1.1)
Class Order Family Genus/Species
Susceptible Aves Galliformes Phasianidae Gallus gallus
Meleagris gallopavo
pheasants (not speciﬁed)
quails (not speciﬁed)
Odontophoridae Not speciﬁed
Numididae Not speciﬁed
Passeriformes Passeridae Not speciﬁed
Fringillidae Serinus spp.
Pyrrhula spp.
Psittaciformes Not speciﬁed
Mammalia Rodentia Muridae Mus spp.
Rattus spp.
Caviidae Cavia porcellus
Chinchillidae Chinchilla spp.
Primates Hominidae Pan spp.
Lagomorpha Leporidae Not speciﬁed
Artiodactyla Suidae Sus spp.
Bovidae Bos spp.
Carnivora Felidae Felis catus
Canidae Vulpes vulpes
Canis lupus
Mustelidae Neovison spp.
Mustela spp.
5 A vector is a living organism that transmits an infectious agent from an infected animal to a human or another animal. Vectors
are frequently arthropods. Biological vectors may carry pathogens that can multiply within their bodies and be delivered to new
hosts, usually by biting. In mechanical vectors, the pathogens do not multiply within the vector, which usually remains infected
for shorter time than in biological vectors.
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Class Order Family Genus/Species
Reservoir Aves Galliformes Phasianidae Quails (not speciﬁed)
Pheasants (not speciﬁed)
Gallus gallus
Peafowl (not speciﬁed)
Odontophoridae not speciﬁed
Anseriformes Anatidae Anas platyrhynchos
Anser anser
Passeriformes Passeridae Not speciﬁed
Columbiformes Columbidae Not speciﬁed
Psittaciformes Not speciﬁed
Mammalia Rodentia Muridae Rattus spp.
Vectors None
Table 18: Main animal species to be listed for Salmonella Gallinarum infection in poultry according
to criteria of Article 8 (source: data reported in Section 3.1.1.1)
Class Order Family Genus/Species
Susceptible Aves Galliformes Phasianidae Gallus gallus
Meleagris gallopavo
Partridges (not speciﬁed)
Pheasants (not speciﬁed)
Quails (not speciﬁed)
Peafowl (not speciﬁed)
Odontophoridae Not speciﬁed
Passeriformes Passeridae Not speciﬁed
Corvidae Corvus frugilegus
Coloeus monedula
Psittaciformes Not speciﬁed
Columbiformes Columbidae Streptopelia capicola
Struthioniformes Struthionidae Struthio camelus
Mammalia Lagomorpha Leporidae Not speciﬁed
Rodentia Muridae Rattus spp.
Reservoir Aves Galliformes Phasianidae Gallus gallus
Passeriformes Corvidae Not speciﬁed
Columbiformes Columbidae Not speciﬁed
Psittaciformes Not speciﬁed
Anseriformes Anatidae Anas platyrhynchos
Anser anser
Mammalia Rodentia Muridae Rattus spp.
Arachnida Mesostigmata Dermanyssidae Dermanyssus gallinae
Ixodida Argasidae Argas spp.
Vectors Mammalia Rodentia Not speciﬁed
Arachnida Mesostigmata Dermanyssidae Dermanyssus gallinae
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4. Conclusions
TOR 1: for each of those diseases an assessment, following the criteria laid down in Article 7 of
the AHL, on its eligibility of being listed for Union intervention as laid down in Article 5(3) of the AHL;
• According to the assessment here performed, Salmonella infection in poultry with serotypes of
animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae) complies with all criteria
of the ﬁrst set and with two criteria of the second set and therefore can be considered eligible
to be listed for Union intervention as laid down in Article 5(3) of the AHL.
TOR 2a: for each of the diseases which was found eligible to be listed for Union intervention, an
assessment of its compliance with each of the criteria in Annex IV to the AHL for the purpose of
categorisation of diseases in accordance with Article 9 of the AHL;
• According to the assessment here performed, Salmonella infection in poultry with serotypes of
animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae) meets the criteria as in
Sections 4 and 5 of Annex IV of the AHL, for the application of the disease prevention and
control rules referred to in points (d) and (e) of Article 9(1) of the AHL. According to the
assessment here performed, it is inconclusive whether Salmonella infection in poultry with
serotypes of animal health relevance (S. Pullorum, S. Gallinarum and S. arizonae) complies
with the criteria as in Section 1 of Annex IV of the AHL, for the application of the disease
prevention and control rules referred to in point (a) of Article 9(1) of the AHL. Compliance of
Salmonella infection in poultry with serotypes of animal health relevance (S. Pullorum,
S. Gallinarum and S. arizonae) with the criteria as in Section 1 is dependent on a decision on
criteria 1 and 2.1.
TOR 2b: for each of the diseases which was found eligible to be listed for Union intervention, a list
of animal species that should be considered candidates for listing in accordance with Article 8 of the
AHL.
• According to the assessment here performed, the main animal species that can be considered
to be listed for Salmonella infection in poultry with serotypes of animal health relevance
(S. Pullorum, S. Gallinarum and S. arizonae) according to Article 8(3) of the AHL are all species
of domestic poultry and wild species of mainly Anseriformes and Galliformes, as reported in
Tables 17–19 in Section 3.4 of the present document.
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